这是一篇来自已证抗体库的有关人类 B细胞淋巴瘤2相关的X蛋白 (Bax) 的综述,是根据379篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合B细胞淋巴瘤2相关的X蛋白 抗体。
B细胞淋巴瘤2相关的X蛋白 同义词: BCL2L4

艾博抗(上海)贸易有限公司
domestic rabbit 单克隆(E63)
  • 免疫印迹; 小鼠; 图 s7a
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在小鼠样本上 (图 s7a). iScience (2022) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 3c
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab53154)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3c). Oncol Lett (2022) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 图 6f
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上 (图 6f). J Cancer (2021) ncbi
domestic rabbit 单克隆(EPR18283)
  • 免疫印迹; 小鼠; 图 6a
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab182733)被用于被用于免疫印迹在小鼠样本上 (图 6a). Theranostics (2021) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:1000; 图 4c
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4c). Int J Oncol (2021) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:1000; 图 1e, 3f
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1e, 3f). Aging (Albany NY) (2021) ncbi
domestic rabbit 单克隆(EPR18283)
  • 免疫印迹; 小鼠; 图 7c
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab182733)被用于被用于免疫印迹在小鼠样本上 (图 7c). Int J Biol Sci (2021) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:1000; 图 4e
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4e). Int J Oncol (2021) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 图 7
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上 (图 7). Aging (Albany NY) (2021) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:1000; 图 5f
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5f). Front Pharmacol (2021) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 小鼠; 图 4h
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在小鼠样本上 (图 4h). Redox Biol (2021) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:2000; 图 4a
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 4a). Front Oncol (2021) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 图 3c
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上 (图 3c). Aging (Albany NY) (2021) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 小鼠; 1:2000; 图 3g
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 3g). Aging (Albany NY) (2021) ncbi
domestic rabbit 单克隆(E63)
  • 免疫组化; 小鼠; 1:200
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫组化在小鼠样本上浓度为1:200. Oncol Rep (2021) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:5000; 图 6
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 6). Mol Med Rep (2021) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 小鼠; 图 5b
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在小鼠样本上 (图 5b). J Am Heart Assoc (2021) ncbi
domestic rabbit 单克隆(EPR18283)
  • 免疫印迹; 小鼠; 图 2g
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab182733)被用于被用于免疫印迹在小鼠样本上 (图 2g). Aging (Albany NY) (2021) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 图 3a
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上 (图 3a). Oncol Lett (2021) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 大鼠; 图 5d
  • 免疫印迹; 人类; 1:1000; 图 1d
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在大鼠样本上 (图 5d) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 1d). Ann Transl Med (2021) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 大鼠; 1:1000; 图 4b
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 4b). J Int Med Res (2021) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:1000; 图 5d
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5d). Mol Med Rep (2021) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 图 5c
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上 (图 5c). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 大鼠; 1:500; 图 6e
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 6e). Cell Death Dis (2021) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 图 s5h
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上 (图 s5h). Theranostics (2021) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 小鼠; 图 6d
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在小鼠样本上 (图 6d). Aging (Albany NY) (2020) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 小鼠; 1:2000; 图 5b
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 5b). Cell Death Dis (2020) ncbi
domestic rabbit 单克隆(E63)
  • 免疫组化; 小鼠; 1:1000; 图 9d
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫组化在小鼠样本上浓度为1:1000 (图 9d). Aging (Albany NY) (2020) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 小鼠; 1:500; 图 2d
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 2d). Int J Med Sci (2020) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:2000; 图 7a
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 7a). Asian Pac J Cancer Prev (2020) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:1000; 图 3c
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3c). Aging (Albany NY) (2020) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:250; 图 3e
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:250 (图 3e). Cancer Res Treat (2021) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:2000; 图 6a
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 6a). Int J Mol Med (2020) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:1000; 图 4f
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4f). BMC Cancer (2020) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:1000
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:1000. Int J Oncol (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:500; 图 2b, 4d
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab53154)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 2b, 4d). Mol Ther Nucleic Acids (2020) ncbi
domestic rabbit 单克隆(E63)
  • 免疫细胞化学; 人类; 1:100; 图 1d
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 1d). Biosci Rep (2020) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 小鼠; 1:1000; 图 6a
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6a). J Transl Med (2020) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 图 2e
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上 (图 2e). EBioMedicine (2020) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 大鼠; 1:1000; 图 6e
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 6e). Front Neurosci (2019) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 大鼠; 1:2000; 图 1e, 2c, 5g
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在大鼠样本上浓度为1:2000 (图 1e, 2c, 5g). J Neuroinflammation (2020) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 大鼠; 1:1000; 图 4a
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 4a). Aging (Albany NY) (2020) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 图 8
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上 (图 8). Biomolecules (2020) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 图 4h
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上 (图 4h). Aging (Albany NY) (2019) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 图 1f
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上 (图 1f). BMC Cancer (2019) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 图 3c
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上 (图 3c). Aging (Albany NY) (2019) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:2000; 图 2d, 2e
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 2d, 2e). Int J Oncol (2019) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:1000; 图 2b
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2b). Cell Death Dis (2019) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 图 s3
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上 (图 s3). Int J Biol Sci (2019) ncbi
domestic rabbit 单克隆(EPR18283)
  • 免疫印迹; 人类; 1:2000; 图 5b
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab182733)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 5b). Biol Res (2019) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:1000; 图 9a
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 9a). Biosci Rep (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 图 2b
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab53154)被用于被用于免疫印迹在大鼠样本上 (图 2b). J Comp Neurol (2019) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 图 1c
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上 (图 1c). Eur Rev Med Pharmacol Sci (2019) ncbi
domestic rabbit 单克隆(EPR18284)
  • 免疫印迹; 人类; 1:1000; 图 8a, 8h
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab182734)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 8a, 8h). Biosci Rep (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:2000; 图 3b
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab53154)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 3b). Biosci Rep (2019) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 图 2c
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上 (图 2c). Redox Biol (2019) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:2000; 图 5a
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 5a). J Cell Physiol (2019) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:2000; 图 4b
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 4b). Biosci Rep (2018) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 图 5a
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上 (图 5a). J Mol Neurosci (2018) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:1000; 图 3c
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3c). Exp Ther Med (2017) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 大鼠; 1:1000; 图 7a
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 7a). Am J Transl Res (2017) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 小鼠; 1:1000; 图 2e
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2e). J Mol Neurosci (2017) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:1000; 图 4b
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4b). Int J Cancer (2017) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 小鼠; 图 6g
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在小鼠样本上 (图 6g). Cell Death Dis (2016) ncbi
domestic rabbit 单克隆(EPR18283)
  • 免疫印迹; 大鼠; 1:500; 图 3a
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab182733)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 3a). Sci Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 4c
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab111391)被用于被用于免疫印迹在人类样本上 (图 4c). Oncotarget (2016) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:1000; 图 4
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4). Onco Targets Ther (2016) ncbi
domestic rabbit 单克隆(E63)
  • 免疫组化-石蜡切片; 小鼠; 1:50; 图 s5
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, 32503)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:50 (图 s5). Nat Commun (2016) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 图 7a
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上 (图 7a). Sci Rep (2016) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:2000; 图 s2
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 s2). Nat Commun (2016) ncbi
domestic rabbit 单克隆(E63)
  • 免疫组化-冰冻切片; 大鼠; 1:200; 图 3
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫组化-冰冻切片在大鼠样本上浓度为1:200 (图 3). Exp Ther Med (2016) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:1000; 图 3b
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3b). Mol Med Rep (2016) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 大鼠; 1:1000; 图 6
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 6). Front Mol Neurosci (2016) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 小鼠; 图 2e
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在小鼠样本上 (图 2e). Mol Med Rep (2016) ncbi
domestic rabbit 单克隆(E63)
  • 免疫沉淀; 大鼠; 图 4
  • 免疫印迹; 大鼠; 图 4
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫沉淀在大鼠样本上 (图 4) 和 被用于免疫印迹在大鼠样本上 (图 4). Am J Physiol Heart Circ Physiol (2015) ncbi
domestic rabbit 单克隆(E63)
  • 免疫组化-石蜡切片; 大鼠; 1:500; 图 6a
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫组化-石蜡切片在大鼠样本上浓度为1:500 (图 6a). Mol Cell Endocrinol (2016) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 大鼠; 1:1000; 图 8a
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 8a). J Proteomics (2016) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 图 5
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上 (图 5). Nucleic Acids Res (2016) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:2000; 图 1b
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 1b). Oncotarget (2015) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 大鼠
  • 免疫细胞化学; 人类
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在大鼠样本上 和 被用于免疫细胞化学在人类样本上. Toxicol Lett (2015) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹基因敲除验证; 仓鼠; 1:2000; 图 2
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹基因敲除验证在仓鼠样本上浓度为1:2000 (图 2). Biotechnol J (2015) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 大鼠
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在大鼠样本上. Exp Neurol (2015) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 大鼠
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, Ab32503)被用于被用于免疫印迹在大鼠样本上. Apoptosis (2015) ncbi
domestic rabbit 单克隆(E63)
  • 免疫组化-石蜡切片; 人类; 1:5000
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Epitomics, ab32503)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:5000. J Am Coll Surg (2014) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 小鼠; 1:1000
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. PLoS ONE (2014) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上. Mol Med Rep (2014) ncbi
domestic rabbit 单克隆(E63)
  • 免疫印迹; 人类; 1:1000
艾博抗(上海)贸易有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abcam, ab32503)被用于被用于免疫印迹在人类样本上浓度为1:1000. FEBS Lett (2013) ncbi
圣克鲁斯生物技术
小鼠 单克隆(B-9)
  • 免疫印迹; 大鼠; 1:1000; 图 2h
  • 免疫组化-石蜡切片; 小鼠; 1:200; 图 5e, 5f
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-7480)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 2h) 和 被用于免疫组化-石蜡切片在小鼠样本上浓度为1:200 (图 5e, 5f). Front Pharmacol (2022) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 人类; 1:1000; 图 6e
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-7480)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6e). Front Oncol (2021) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 人类; 图 4a
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-7480)被用于被用于免疫印迹在人类样本上 (图 4a). Front Immunol (2021) ncbi
小鼠 单克隆(2D2)
  • 免疫印迹; 人类; 图 8d, 8e
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-20067)被用于被用于免疫印迹在人类样本上 (图 8d, 8e). Cancer Cell Int (2021) ncbi
小鼠 单克隆(6A7)
  • 免疫印迹; 小鼠; 1:500; 图 8d
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, 6A7)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 8d). Cell Death Dis (2020) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 人类; 图 3a
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-7480)被用于被用于免疫印迹在人类样本上 (图 3a). Antioxidants (Basel) (2020) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 小鼠; 1:300; 图 4b
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-7480)被用于被用于免疫印迹在小鼠样本上浓度为1:300 (图 4b). Med Sci Monit (2020) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 大鼠; 1:1500; 图 2c
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa, sc-7480)被用于被用于免疫印迹在大鼠样本上浓度为1:1500 (图 2c). Biomolecules (2019) ncbi
  • 免疫细胞化学; 人类; 图 6a
  • 免疫印迹; 人类; 图 7a
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, N20)被用于被用于免疫细胞化学在人类样本上 (图 6a) 和 被用于免疫印迹在人类样本上 (图 7a). Cell Death Dis (2019) ncbi
小鼠 单克隆(2D2)
  • 免疫印迹; 人类; 1:2000; 图 3c
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-20067)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 3c). Front Endocrinol (Lausanne) (2019) ncbi
  • 免疫印迹; 小鼠; 图 4c
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa, N-20)被用于被用于免疫印迹在小鼠样本上 (图 4c). J Clin Invest (2019) ncbi
  • 免疫印迹; 人类; 图 4b
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, N-20)被用于被用于免疫印迹在人类样本上 (图 4b). Cell Death Dis (2019) ncbi
  • 免疫印迹; 小鼠; 图 4f
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa, N-20)被用于被用于免疫印迹在小鼠样本上 (图 4f). J Exp Med (2019) ncbi
小鼠 单克隆(4H32)
  • 免疫印迹; 大鼠; 1:1000; 图 2c
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa, sc-70,407)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 2c). BMC Complement Altern Med (2019) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 小鼠; 1:200; 图 4b
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-7480)被用于被用于免疫印迹在小鼠样本上浓度为1:200 (图 4b). Cardiovasc Res (2018) ncbi
小鼠 单克隆(B-9)
  • 免疫细胞化学; 人类; 图 2c
  • 免疫印迹; 人类; 1:400; 图 5a
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-7480)被用于被用于免疫细胞化学在人类样本上 (图 2c) 和 被用于免疫印迹在人类样本上浓度为1:400 (图 5a). J Biol Chem (2018) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 人类; 图 3d
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology Inc, sc-7480)被用于被用于免疫印迹在人类样本上 (图 3d). PLoS ONE (2018) ncbi
小鼠 单克隆(6A7)
  • 免疫印迹; 人类; 1:200; 图 3b
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, 6A7)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 3b). Hepatology (2017) ncbi
小鼠 单克隆(6A7)
  • 免疫印迹; 犬; 图 s5b
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology Inc, sc-23959)被用于被用于免疫印迹在犬样本上 (图 s5b). Oncogene (2017) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 人类; 图 5d
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-7480)被用于被用于免疫印迹在人类样本上 (图 5d). Cell Physiol Biochem (2017) ncbi
小鼠 单克隆(4H32)
  • 免疫印迹; 人类; 1:2000; 图 2C
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa cruz, sc-70407)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 2C). Mol Med Rep (2017) ncbi
小鼠 单克隆(2D2)
  • 免疫印迹; 人类; 1:1000; 图 3b
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-20067)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3b). Apoptosis (2017) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 人类; 图 4a
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-7480)被用于被用于免疫印迹在人类样本上 (图 4a). Anticancer Res (2017) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 小鼠; 1:500; 图 5c
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-7480)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 5c). PLoS ONE (2017) ncbi
  • 免疫印迹; 小鼠; 图 4a
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc493)被用于被用于免疫印迹在小鼠样本上 (图 4a). PLoS ONE (2017) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 人类; 1:1000; 图 2d
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-7480)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2d). Int J Mol Med (2017) ncbi
  • 免疫印迹; 人类; 1:1000; 图 2a
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, N-20)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2a). Mol Cell Biol (2017) ncbi
小鼠 单克隆(B-9)
  • 免疫组化-石蜡切片; 人类; 1:500; 图 4G
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-7480)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:500 (图 4G). Oncotarget (2017) ncbi
小鼠 单克隆(2D2)
  • 免疫印迹; 人类; 图 10a
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-20067)被用于被用于免疫印迹在人类样本上 (图 10a). Onco Targets Ther (2017) ncbi
  • 免疫印迹; 人类; 图 4c
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-493)被用于被用于免疫印迹在人类样本上 (图 4c). Peerj (2017) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; gerbils; 1:1000; 图 5
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, SC-7480)被用于被用于免疫印迹在gerbils样本上浓度为1:1000 (图 5). Exp Ther Med (2017) ncbi
小鼠 单克隆(2D2)
  • 免疫印迹; 人类; 1:2000; 图 4a
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-20067)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 4a). Exp Ther Med (2016) ncbi
小鼠 单克隆(6A7)
  • 免疫印迹; 小鼠; 图 2b
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-23959)被用于被用于免疫印迹在小鼠样本上 (图 2b). Lab Invest (2017) ncbi
  • 免疫印迹; 人类; 图 2a
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, N-20)被用于被用于免疫印迹在人类样本上 (图 2a). Biochem Biophys Res Commun (2017) ncbi
  • 免疫印迹; 人类; 1:1000; 图 4b
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-493)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4b). Oncol Lett (2016) ncbi
  • 免疫组化-石蜡切片; 大鼠; 1:200; 图 9a,9b
  • 免疫印迹; 大鼠; 1:200; 图 9d
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-493)被用于被用于免疫组化-石蜡切片在大鼠样本上浓度为1:200 (图 9a,9b) 和 被用于免疫印迹在大鼠样本上浓度为1:200 (图 9d). Oncotarget (2016) ncbi
  • 免疫印迹; 人类; 图 4c
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-493)被用于被用于免疫印迹在人类样本上 (图 4c). Nature (2016) ncbi
  • 免疫印迹; 人类; 1:500; 图 5a
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc - 493)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 5a). Toxicol Appl Pharmacol (2016) ncbi
  • 免疫印迹; 人类; 图 4e
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-493)被用于被用于免疫印迹在人类样本上 (图 4e). Oncotarget (2016) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 大鼠; 1:250; 图 3a
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, Sc-7480)被用于被用于免疫印迹在大鼠样本上浓度为1:250 (图 3a). Alcohol (2016) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 人类; 1:1000; 图 1g
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-7480)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1g). Mol Med Rep (2016) ncbi
小鼠 单克隆(2D2)
  • 免疫印迹; 人类; 图 2
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, 20067)被用于被用于免疫印迹在人类样本上 (图 2). BMC Cancer (2016) ncbi
小鼠 单克隆(2D2)
  • 免疫印迹; 人类; 1:1000; 图 4
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc20067)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4). Oncol Lett (2016) ncbi
小鼠 单克隆(2D2)
  • 免疫印迹; 人类; 图 4a
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-20067)被用于被用于免疫印迹在人类样本上 (图 4a). Cell Biochem Biophys (2016) ncbi
  • 免疫印迹; 人类; 图 1a
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, N-20)被用于被用于免疫印迹在人类样本上 (图 1a). Oncotarget (2016) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 人类; 图 2
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-7480)被用于被用于免疫印迹在人类样本上 (图 2). Biomed Rep (2016) ncbi
小鼠 单克隆(2D2)
  • 流式细胞仪; 人类; 图 4a
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-20067)被用于被用于流式细胞仪在人类样本上 (图 4a). Eur J Cell Biol (2016) ncbi
小鼠 单克隆(2D2)
  • 免疫印迹; 大鼠; 1:1000; 图 4
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-20067)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 4). Exp Ther Med (2016) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 大鼠; 1:1000; 图 4
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-7480)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 4). Int J Mol Med (2016) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 人类; 图 4
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-7480)被用于被用于免疫印迹在人类样本上 (图 4). BMC Cancer (2016) ncbi
小鼠 单克隆(6D149)
  • 免疫印迹; 人类; 1:200; 图 5
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-70405)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 5). Oncol Lett (2016) ncbi
  • 免疫印迹; 人类; 图 2a
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, N-20)被用于被用于免疫印迹在人类样本上 (图 2a). Biochem Biophys Res Commun (2016) ncbi
小鼠 单克隆(2D2)
  • 流式细胞仪; 人类; 图 3a, 3b, 3c, 3d
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-20067PE)被用于被用于流式细胞仪在人类样本上 (图 3a, 3b, 3c, 3d). Nutr Cancer (2016) ncbi
小鼠 单克隆(6A7)
  • 免疫印迹; pigs ; 图 3
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(santa Cruz, sc-23959)被用于被用于免疫印迹在pigs 样本上 (图 3). Peerj (2016) ncbi
小鼠 单克隆(B-9)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 1
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-7480)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 1). Oncol Lett (2015) ncbi
  • 其他; 人类; 图 st1
  • 免疫印迹; 人类; 图 st4
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(SCBT, N-20)被用于被用于其他在人类样本上 (图 st1) 和 被用于免疫印迹在人类样本上 (图 st4). Mol Cell Proteomics (2016) ncbi
小鼠 单克隆(B-9)
  • 其他; 人类; 图 st1
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(SCBT, B-9)被用于被用于其他在人类样本上 (图 st1). Mol Cell Proteomics (2016) ncbi
小鼠 单克隆(2D2)
  • 免疫印迹; 小鼠; 图 1d
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-20067)被用于被用于免疫印迹在小鼠样本上 (图 1d). Int J Mol Med (2016) ncbi
小鼠 单克隆(B-9)
  • 免疫组化-石蜡切片; 人类; 1:250; 图 6g
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(SantaCruz, sc7480)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:250 (图 6g). Cancer Cell (2016) ncbi
小鼠 单克隆(4H32)
  • 免疫组化; 大鼠; 图 2
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-70407)被用于被用于免疫组化在大鼠样本上 (图 2). Nutr Cancer (2016) ncbi
  • 免疫印迹; 人类; 图 1
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, N-20)被用于被用于免疫印迹在人类样本上 (图 1). Cancer Biol Ther (2016) ncbi
小鼠 单克隆(2D2)
  • 免疫印迹; 人类; 1:2000; 图 5a
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-20067)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 5a). Mol Med Rep (2016) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 大鼠; 1:1000; 图 2
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-7480)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 2). Neuroscience (2015) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 大鼠; 1:500; 图 2
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-7480)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 2). Mol Brain (2015) ncbi
  • 免疫印迹; 小鼠; 图 4e
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc493)被用于被用于免疫印迹在小鼠样本上 (图 4e). PLoS ONE (2015) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 人类; 图 4
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-7480)被用于被用于免疫印迹在人类样本上 (图 4). PLoS ONE (2015) ncbi
小鼠 单克隆(2D2)
  • 免疫印迹; 人类; 图 3
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-20067)被用于被用于免疫印迹在人类样本上 (图 3). Oncotarget (2015) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 小鼠; 图 5
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-7480)被用于被用于免疫印迹在小鼠样本上 (图 5). Cancer Sci (2015) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 小鼠; 图 7
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, B-9)被用于被用于免疫印迹在小鼠样本上 (图 7). PLoS ONE (2015) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 人类; 图 3
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(santa Cruz, sc-7480)被用于被用于免疫印迹在人类样本上 (图 3). Sci Rep (2015) ncbi
小鼠 单克隆(2D2)
  • 免疫印迹; 人类; 图 2
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-20067)被用于被用于免疫印迹在人类样本上 (图 2). Acta Pharmacol Sin (2015) ncbi
小鼠 单克隆(B-9)
  • 免疫组化-石蜡切片; domestic rabbit; 1:500; 图 3
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(santa Cruz, sc-7480)被用于被用于免疫组化-石蜡切片在domestic rabbit样本上浓度为1:500 (图 3). Oxid Med Cell Longev (2015) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 人类
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, B-9)被用于被用于免疫印迹在人类样本上. Nucleic Acids Res (2015) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-7480)被用于被用于免疫印迹在小鼠样本上. Neuromolecular Med (2015) ncbi
  • 免疫印迹; 人类; 图 2a
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-493)被用于被用于免疫印迹在人类样本上 (图 2a). Oncotarget (2015) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 大鼠; 1:200; 图 5
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-7480)被用于被用于免疫印迹在大鼠样本上浓度为1:200 (图 5). Mol Med Rep (2015) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 人类; 图 5
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, SC-7480)被用于被用于免疫印迹在人类样本上 (图 5). Cell Death Dis (2015) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 小鼠; 1:200
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-7480)被用于被用于免疫印迹在小鼠样本上浓度为1:200. FASEB J (2015) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-7480)被用于被用于免疫印迹在人类样本上浓度为1:1000. Mol Med Rep (2015) ncbi
小鼠 单克隆(2D2)
  • 免疫印迹; 人类; 图 3
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(santa Cruz, sc-20067)被用于被用于免疫印迹在人类样本上 (图 3). Oncotarget (2015) ncbi
小鼠 单克隆(SPM336)
  • 免疫印迹; 人类; 1:200; 图 3
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-65532)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 3). Oncol Lett (2015) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 小鼠; 图 5
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-7480)被用于被用于免疫印迹在小鼠样本上 (图 5). Int J Biol Sci (2015) ncbi
小鼠 单克隆(2D2)
  • 免疫印迹; 人类
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-20067)被用于被用于免疫印迹在人类样本上. Biochim Biophys Acta (2015) ncbi
小鼠 单克隆(2D2)
  • 免疫印迹; 人类
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-20067)被用于被用于免疫印迹在人类样本上. Biochim Biophys Acta (2015) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 人类
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-7480)被用于被用于免疫印迹在人类样本上. Oncotarget (2015) ncbi
小鼠 单克隆(B-9)
  • 免疫组化-石蜡切片; 小鼠
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa cruz, SC-7480)被用于被用于免疫组化-石蜡切片在小鼠样本上. Oncotarget (2014) ncbi
小鼠 单克隆(B-9)
  • 免疫组化-石蜡切片; 人类; 图 5
  • 免疫印迹; 人类; 1:500; 图 5
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-7480)被用于被用于免疫组化-石蜡切片在人类样本上 (图 5) 和 被用于免疫印迹在人类样本上浓度为1:500 (图 5). Oncol Rep (2014) ncbi
小鼠 单克隆(2D2)
  • 免疫印迹; 人类; 图 1
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-20067)被用于被用于免疫印迹在人类样本上 (图 1). Biochim Biophys Acta (2014) ncbi
小鼠 单克隆(6A7)
  • 免疫印迹; 大鼠; 1:500
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Technology, sc-23959)被用于被用于免疫印迹在大鼠样本上浓度为1:500. Age (Dordr) (2014) ncbi
小鼠 单克隆(2D2)
  • 免疫印迹; 人类
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-20067)被用于被用于免疫印迹在人类样本上. Cell Death Dis (2014) ncbi
小鼠 单克隆(B-9)
  • 免疫组化; 小鼠; 1:100
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-7480)被用于被用于免疫组化在小鼠样本上浓度为1:100. J Neurosci (2014) ncbi
小鼠 单克隆(6A7)
  • 免疫沉淀; 小鼠
  • 免疫印迹; 小鼠
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-23959)被用于被用于免疫沉淀在小鼠样本上 和 被用于免疫印迹在小鼠样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(6D149)
  • 免疫沉淀; 人类
  • 免疫印迹; 人类
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-70405)被用于被用于免疫沉淀在人类样本上 和 被用于免疫印迹在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(YTH6A7)
  • 免疫印迹; 小鼠; 1:300-1:600; 图 6
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, Sc-80658)被用于被用于免疫印迹在小鼠样本上浓度为1:300-1:600 (图 6). J Neuroinflammation (2014) ncbi
小鼠 单克隆(6A7)
  • 免疫印迹; 小鼠; 图 4
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-23959)被用于被用于免疫印迹在小鼠样本上 (图 4). J Am Soc Nephrol (2014) ncbi
小鼠 单克隆(6A7)
  • 免疫印迹; 人类
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, 6A7)被用于被用于免疫印迹在人类样本上. BMC Cancer (2014) ncbi
小鼠 单克隆(6A7)
  • 免疫沉淀; 人类
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-23959)被用于被用于免疫沉淀在人类样本上. Apoptosis (2014) ncbi
小鼠 单克隆(6A7)
  • 免疫细胞化学; 小鼠; 1:200
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-23959)被用于被用于免疫细胞化学在小鼠样本上浓度为1:200. Cell Death Differ (2013) ncbi
小鼠 单克隆(6A7)
  • 免疫细胞化学; 人类; 1:500
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa, 6A7)被用于被用于免疫细胞化学在人类样本上浓度为1:500. J Biol Chem (2011) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 人类; 1:200
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz Biotechnology, sc-7480)被用于被用于免疫印迹在人类样本上浓度为1:200. Gut (2007) ncbi
小鼠 单克隆(6A7)
  • 免疫沉淀; 猕猴
  • 免疫印迹; 猕猴
圣克鲁斯生物技术B细胞淋巴瘤2相关的X蛋白抗体(Santa Cruz, sc-23959)被用于被用于免疫沉淀在猕猴样本上 和 被用于免疫印迹在猕猴样本上. J Virol (2007) ncbi
赛默飞世尔
小鼠 单克隆(6A7)
  • 免疫印迹; 小鼠; 1:1000; 图 4d
赛默飞世尔B细胞淋巴瘤2相关的X蛋白抗体(Thermo Fishers, MA5-14003)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4d). Antioxidants (Basel) (2021) ncbi
小鼠 单克隆(6A7)
  • 免疫组化; 人类; 1:500; 图 8e
  • 免疫印迹; 人类; 图 2d
赛默飞世尔B细胞淋巴瘤2相关的X蛋白抗体(Thermo Scientific, MA5-14003)被用于被用于免疫组化在人类样本上浓度为1:500 (图 8e) 和 被用于免疫印迹在人类样本上 (图 2d). Cancers (Basel) (2021) ncbi
小鼠 单克隆(6A7)
  • 免疫细胞化学; 人类; 图 5c
赛默飞世尔B细胞淋巴瘤2相关的X蛋白抗体(Thermo Fisher, 14-6997-81)被用于被用于免疫细胞化学在人类样本上 (图 5c). Cell (2019) ncbi
小鼠 单克隆(2D2)
  • 免疫印迹; 人类; 图 5a
赛默飞世尔B细胞淋巴瘤2相关的X蛋白抗体(Invitrogen, 336400)被用于被用于免疫印迹在人类样本上 (图 5a). PLoS ONE (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 图 5
赛默飞世尔B细胞淋巴瘤2相关的X蛋白抗体(Thermo Fisher Scientific, PA1-41325)被用于被用于免疫组化-石蜡切片在人类样本上 (图 5). Sci Rep (2016) ncbi
小鼠 单克隆(2D2)
  • 免疫细胞化学; 人类; 图 3
赛默飞世尔B细胞淋巴瘤2相关的X蛋白抗体(Thermo Fisher Scientific, 2D2)被用于被用于免疫细胞化学在人类样本上 (图 3). Cell Death Differ (2016) ncbi
小鼠 单克隆(6A7)
  • 流式细胞仪; 人类
赛默飞世尔B细胞淋巴瘤2相关的X蛋白抗体(Thermo Scientific, MA5-14003)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(2D2)
  • 免疫组化-石蜡切片; 人类; 1:25
赛默飞世尔B细胞淋巴瘤2相关的X蛋白抗体(LabVisio, 2D2)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:25. APMIS (2015) ncbi
小鼠 单克隆(6A7)
  • 免疫组化-石蜡切片; 大鼠; 1:50
赛默飞世尔B细胞淋巴瘤2相关的X蛋白抗体(Thermo Scientific, MA5-14003)被用于被用于免疫组化-石蜡切片在大鼠样本上浓度为1:50. Diabetol Metab Syndr (2014) ncbi
小鼠 单克隆(2D2)
  • 免疫印迹; 人类; 图 5
赛默飞世尔B细胞淋巴瘤2相关的X蛋白抗体(Zymed, 33?C6400)被用于被用于免疫印迹在人类样本上 (图 5). Biochim Biophys Acta (2013) ncbi
小鼠 单克隆(2D2)
  • 免疫组化-石蜡切片; 人类; 1:100
赛默飞世尔B细胞淋巴瘤2相关的X蛋白抗体(Invitrogen, 33-6400)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. Int J Oncol (2012) ncbi
小鼠 单克隆(2D2)
  • 免疫印迹; 人类; 图 8
赛默飞世尔B细胞淋巴瘤2相关的X蛋白抗体(Zymed, 33-6400)被用于被用于免疫印迹在人类样本上 (图 8). FASEB J (2011) ncbi
小鼠 单克隆(6A7)
  • 免疫组化-石蜡切片; 人类; 1:50; 图 2A
赛默飞世尔B细胞淋巴瘤2相关的X蛋白抗体(Biosource, 6A7)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (图 2A). Neuropathology (2008) ncbi
小鼠 单克隆(6A7)
  • 免疫印迹; 人类
赛默飞世尔B细胞淋巴瘤2相关的X蛋白抗体(Neomarkers, 6A7)被用于被用于免疫印迹在人类样本上. Biochem Biophys Res Commun (2007) ncbi
小鼠 单克隆(2D2)
  • 免疫组化-石蜡切片; 人类; 1:50
赛默飞世尔B细胞淋巴瘤2相关的X蛋白抗体(Zymed, ZD2)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50. Eur J Cancer Prev (2006) ncbi
小鼠 单克隆(2D2)
  • 免疫组化-石蜡切片; 人类; 1:50
赛默飞世尔B细胞淋巴瘤2相关的X蛋白抗体(Zymed, 33-6400)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50. J Mol Histol (2005) ncbi
小鼠 单克隆(2D2)
  • 免疫组化; 人类; 1:100; 表 2
赛默飞世尔B细胞淋巴瘤2相关的X蛋白抗体(Neo Markers, 2D2)被用于被用于免疫组化在人类样本上浓度为1:100 (表 2). J Cutan Pathol (2004) ncbi
小鼠 单克隆(2D2)
  • 免疫组化-石蜡切片; 人类; 1:50; 表 3
赛默飞世尔B细胞淋巴瘤2相关的X蛋白抗体(Zymed, 2D2)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (表 3). Histopathology (2004) ncbi
小鼠 单克隆(2D2)
  • 免疫组化; 人类; 1:40; 图 2
赛默飞世尔B细胞淋巴瘤2相关的X蛋白抗体(Zymed, clone 2D2)被用于被用于免疫组化在人类样本上浓度为1:40 (图 2). J Pathol (2003) ncbi
小鼠 单克隆(2D2)
  • 免疫组化; 人类; 1:150; 图 1-4
赛默飞世尔B细胞淋巴瘤2相关的X蛋白抗体(Zymed Laboratories, clone 2D2)被用于被用于免疫组化在人类样本上浓度为1:150 (图 1-4). Eur Urol (2002) ncbi
小鼠 单克隆(2D2)
  • 免疫组化-石蜡切片; 人类; 1:100; 表 2
赛默飞世尔B细胞淋巴瘤2相关的X蛋白抗体(Zymed, clone 2D2)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (表 2). Clin Cancer Res (2002) ncbi
小鼠 单克隆(2D2)
  • 免疫印迹; 人类; 图 4
赛默飞世尔B细胞淋巴瘤2相关的X蛋白抗体(Zymed, 2D2)被用于被用于免疫印迹在人类样本上 (图 4). J Immunol (1999) ncbi
Novus Biologicals
小鼠 单克隆(6A7)
  • 免疫印迹; 人类; 图 4c
Novus BiologicalsB细胞淋巴瘤2相关的X蛋白抗体(Novus, NBP1-28566)被用于被用于免疫印迹在人类样本上 (图 4c). J Pathol (2019) ncbi
小鼠 单克隆(6A7)
  • 免疫印迹; 大鼠; 1:500; 图 7c
Novus BiologicalsB细胞淋巴瘤2相关的X蛋白抗体(Novus Biologicals, NBP1-28566)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 7c). Neuropharmacology (2018) ncbi
武汉博士德生物工程有限公司
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:2500; 图 7
武汉博士德生物工程有限公司B细胞淋巴瘤2相关的X蛋白抗体(Boster, A00183)被用于被用于免疫印迹在大鼠样本上浓度为1:2500 (图 7). Brain Behav (2020) ncbi
亚诺法生技股份有限公司
小鼠 单克隆(1F5-1B7)
  • 免疫组化-石蜡切片; domestic rabbit; 1:4000
亚诺法生技股份有限公司B细胞淋巴瘤2相关的X蛋白抗体(Abnova Corporation, H00000581-M01)被用于被用于免疫组化-石蜡切片在domestic rabbit样本上浓度为1:4000. Exp Ther Med (2015) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 大鼠; 图 5a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 5023)被用于被用于免疫印迹在大鼠样本上 (图 5a). Int J Mol Sci (2022) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 s1f
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在人类样本上 (图 s1f). Mol Ther Oncolytics (2022) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 4b
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 2772S)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4b). Front Physiol (2022) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:100
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 2772)被用于被用于免疫印迹在小鼠样本上浓度为1:100. Int J Mol Sci (2022) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 图 5a, 5d, 5g, 5j
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 5023)被用于被用于免疫印迹在人类样本上 (图 5a, 5d, 5g, 5j). Cell Oncol (Dordr) (2022) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 1:1000; 图 7c
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 5023)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 7c). iScience (2022) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 图 4c
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 5023)被用于被用于免疫印迹在人类样本上 (图 4c). Cell Death Discov (2022) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 小鼠; 1:1000; 图 2c
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 5023)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2c). J Cell Mol Med (2022) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 4a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 2772)被用于被用于免疫印迹在小鼠样本上 (图 4a). Front Cardiovasc Med (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 8f
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signalling, 2772)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 8f). NPJ Breast Cancer (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 5c
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 2772)被用于被用于免疫印迹在小鼠样本上 (图 5c). Cell Death Dis (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell signaling, 2772 s)被用于被用于免疫印迹在人类样本上 (图 5a). Sci Rep (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:5000; 图 7a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 7a). Oxid Med Cell Longev (2021) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫沉淀; 人类; 图 6d
  • 免疫印迹; 人类; 图 6a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 5023)被用于被用于免疫沉淀在人类样本上 (图 6d) 和 被用于免疫印迹在人类样本上 (图 6a). Cell Death Discov (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 3g
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 2772)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3g). Theranostics (2021) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 大鼠; 1:1000; 图 2c
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 5023S)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 2c). Exp Ther Med (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5b
  • 免疫印迹; 小鼠; 1:1000; 图 5a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 2772S)被用于被用于免疫印迹在人类样本上 (图 5b) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5a). J Cancer (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 图 7b
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在大鼠样本上 (图 7b). Peerj (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 4f
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 2772)被用于被用于免疫印迹在小鼠样本上 (图 4f). Mol Metab (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 图 7f
  • 免疫印迹; 小鼠; 图 6h
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在大鼠样本上 (图 7f) 和 被用于免疫印迹在小鼠样本上 (图 6h). Front Pharmacol (2021) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 1:1000; 图 7d
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 5023)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 7d). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 1:1000; 图 4d, 4f
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 5023)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4d, 4f). J Cell Mol Med (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 2772)被用于被用于免疫印迹在人类样本上 (图 1a). Cell Death Dis (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 4c, 4e
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell signaling technology, 2772)被用于被用于免疫印迹在人类样本上 (图 4c, 4e). Cell Death Dis (2021) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 4a
  • 免疫印迹; 小鼠; 1:1000; 图 7c
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 5023)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 4a) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 7c). Front Pharmacol (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 4f
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signalling, 2772)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4f). Nat Commun (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 6d
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 2772S)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6d). Theranostics (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 4a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 2,772)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4a). Front Pharmacol (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 5b
  • 免疫印迹; 人类; 图 5a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在小鼠样本上 (图 5b) 和 被用于免疫印迹在人类样本上 (图 5a). Cell Death Dis (2021) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 1:100; 图 5b
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 5023)被用于被用于免疫印迹在人类样本上浓度为1:100 (图 5b). Int J Oral Sci (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 3a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3a). Cell Death Differ (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 6a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在人类样本上 (图 6a). Oncogenesis (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 12d
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 2772)被用于被用于免疫印迹在小鼠样本上 (图 12d). Cell Mol Gastroenterol Hepatol (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 5a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5a). Oxid Med Cell Longev (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 6b
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 2772S)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6b). Oxid Med Cell Longev (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 4e
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4e). Cell Prolif (2021) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 图 s2a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 5023)被用于被用于免疫印迹在人类样本上 (图 s2a). Cell Death Dis (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 2a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 2772)被用于被用于免疫印迹在小鼠样本上 (图 2a). Sci Rep (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 s1a, s1e
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2774S)被用于被用于免疫印迹在人类样本上 (图 s1a, s1e). Sci Adv (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:200; 图 s2f
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 2772)被用于被用于免疫印迹在小鼠样本上浓度为1:200 (图 s2f). Clin Transl Med (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 6b
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 2772)被用于被用于免疫印迹在小鼠样本上 (图 6b). Redox Biol (2021) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 小鼠; 图 5c
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 5023)被用于被用于免疫印迹在小鼠样本上 (图 5c). Oxid Med Cell Longev (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 4c
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 2772)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4c). Oncol Rep (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 4g
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4g). elife (2020) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 图 2a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 5023)被用于被用于免疫印迹在人类样本上 (图 2a). BMC Complement Med Ther (2020) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 图 4f
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 5023)被用于被用于免疫印迹在人类样本上 (图 4f). Front Cell Dev Biol (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 3b
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 2772s)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3b). Mol Med Rep (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:500; 图 7a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 7a). Aging (Albany NY) (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 5a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5a). Nat Commun (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 1d
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在小鼠样本上 (图 1d). Drug Des Devel Ther (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 2c
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 2772)被用于被用于免疫印迹在小鼠样本上 (图 2c). Aging (Albany NY) (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:500; 图 5a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772S)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 5a). J Biomed Sci (2020) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 1:1000; 图 4c
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 5023S)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4c). J Cancer (2020) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 1:1000; 图 2f
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 5023S)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2f). Biol Open (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 8
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 2772S)被用于被用于免疫印迹在人类样本上 (图 8). Biomolecules (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 s7
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2774)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s7). Oncogene (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 4a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(cell signaling technologies, 2772)被用于被用于免疫印迹在人类样本上 (图 4a). Front Genet (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 4d
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在小鼠样本上 (图 4d). Cell Death Dis (2019) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 图 2c
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 5023)被用于被用于免疫印迹在人类样本上 (图 2c). Biomed Res Int (2019) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 图 4f
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 5023)被用于被用于免疫印迹在人类样本上 (图 4f). J Clin Invest (2019) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 1:1000; 图 7d
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 5023)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 7d). Int J Oncol (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 3a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772S)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3a). Aging Cell (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 4c
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在人类样本上 (图 4c). Cell Death Dis (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2f
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2774)被用于被用于免疫印迹在人类样本上 (图 2f). Mol Cell Probes (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 5a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 2772)被用于被用于免疫印迹在小鼠样本上 (图 5a). Toxicology (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 6b
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2774)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6b). Cancer Sci (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 2h
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signalling Technology, 2772)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2h). Redox Biol (2019) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 图 2g
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 5023)被用于被用于免疫印迹在人类样本上 (图 2g). Oncogene (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 3b
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 2772)被用于被用于免疫印迹在人类样本上 (图 3b). Oncoimmunology (2018) ncbi
domestic rabbit 多克隆
  • 其他; 人类; 图 4c
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于其他在人类样本上 (图 4c). Cancer Cell (2018) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 4a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2774)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4a). Am J Transl Res (2018) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 1:1000; 图 s3a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 5023)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s3a). Nat Commun (2018) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 6d
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在小鼠样本上 (图 6d). Oncotarget (2017) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 1:1000; 图 s8c
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 5023)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s8c). Nat Med (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2d
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在人类样本上 (图 2d). Gene (2017) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 1:1000; 图 2e
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 5023)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2e). J Drug Target (2017) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 小鼠; 1:1000; 图 4
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell signaling, 5023S)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4). Biomed Rep (2017) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 1:1000; 图 8b
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(cell signalling, 5023)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 8b). Int J Oncol (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2b
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(cell signalling, 2772)被用于被用于免疫印迹在人类样本上 (图 2b). Cell Death Dis (2017) ncbi
domestic rabbit 多克隆
  • reverse phase protein lysate microarray; 人类; 图 st6
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 2772)被用于被用于reverse phase protein lysate microarray在人类样本上 (图 st6). Cancer Cell (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 7
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 7). Oxid Med Cell Longev (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 s2
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(cell signalling, 2774)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s2). Sci Rep (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 7d
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 7d). Theranostics (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 5e
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(cell signalling, 2772)被用于被用于免疫印迹在小鼠样本上 (图 5e). Sci Rep (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 6a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 2772)被用于被用于免疫印迹在人类样本上 (图 6a). Cell Death Dis (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 6a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell signaling, 2772)被用于被用于免疫印迹在人类样本上 (图 6a). Nat Commun (2017) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 1:1000; 图 s2e
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 5023)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s2e). Nat Commun (2017) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 1:1000; 图 3c
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell signaling, D2E11)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3c). Oncol Lett (2016) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 图 2d
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 5023)被用于被用于免疫印迹在人类样本上 (图 2d). FEBS Open Bio (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在人类样本上 (图 5). Reprod Biol (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图 7a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772S)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 7a). Appl Physiol Nutr Metab (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:500
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在大鼠样本上浓度为1:500. J Cell Physiol (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 2772)被用于被用于免疫印迹在人类样本上. Cell Syst (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 5e
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 2772)被用于被用于免疫印迹在小鼠样本上 (图 5e). J Am Heart Assoc (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2b
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在人类样本上 (图 2b). Int J Biochem Cell Biol (2017) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 1:1000; 图 5a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 5023)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5a). Oncotarget (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:2000; 图 7a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2774)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 7a). Int J Mol Sci (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 1g
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1g). EMBO Mol Med (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2b
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在人类样本上 (图 2b). Int J Nanomedicine (2016) ncbi
domestic rabbit 多克隆
  • 免疫沉淀; 人类; 图 4c
  • 免疫印迹; 人类; 图 4c
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫沉淀在人类样本上 (图 4c) 和 被用于免疫印迹在人类样本上 (图 4c). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 3a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在人类样本上 (图 3a). Cancer Gene Ther (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 图 5e
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 2722)被用于被用于免疫印迹在大鼠样本上 (图 5e). PLoS ONE (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:500; 图 6
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 2774)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 6). Oncol Lett (2016) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 图 4b
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 5023S)被用于被用于免疫印迹在人类样本上 (图 4b). Sci Rep (2016) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 1:2000; 图 6c
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 5023)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 6c). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:200; 图 st1
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 st1). Nat Commun (2016) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹基因敲除验证; 人类; 图 3b
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell signaling, 5023)被用于被用于免疫印迹基因敲除验证在人类样本上 (图 3b). Oncotarget (2016) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 图 5d
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 5023)被用于被用于免疫印迹在人类样本上 (图 5d). Cell Death Dis (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 4a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 2772)被用于被用于免疫印迹在人类样本上 (图 4a). Oncotarget (2016) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 图 5b
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 5023)被用于被用于免疫印迹在人类样本上 (图 5b). Int J Mol Sci (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 s3d
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在人类样本上 (图 s3d). Oncotarget (2016) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 图 4b
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 5023)被用于被用于免疫印迹在人类样本上 (图 4b). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 5
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Tech, 2772S)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5). Oncol Lett (2016) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 图 5
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, D2E11)被用于被用于免疫印迹在人类样本上 (图 5). Sci Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2g
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在人类样本上 (图 2g). Antioxid Redox Signal (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 4
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在人类样本上 (图 4). Cell Death Discov (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 3a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(ell Signaling Technology, 2772)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3a). Mol Med Rep (2016) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 1:1000; 图 4b
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 5023)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4b). Exp Ther Med (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 4a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2774)被用于被用于免疫印迹在人类样本上 (图 4a). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 3a
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在人类样本上 (图 3a). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 4
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在人类样本上 (图 4). Mol Brain (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 s6b
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在人类样本上 (图 s6b). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 5
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 2772)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5). Arch Toxicol (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell signaling, 2772)被用于被用于免疫印迹在人类样本上 (图 5). Oncotarget (2016) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 1:1000; 图 1
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Tech, 5023)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 9
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell signaling, 2772S)被用于被用于免疫印迹在人类样本上 (图 9). Life Sci (2016) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 图 s6
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Tech, 5023S)被用于被用于免疫印迹在人类样本上 (图 s6). Sci Signal (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 6d
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在人类样本上 (图 6d). Biochem Pharmacol (2016) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 1:2000; 图 3
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 5023)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 3). Int J Mol Med (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 3d
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772S)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3d). Mol Cancer Ther (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 s1
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 2772)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s1). Nat Commun (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图 4
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technologies, CST2772)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 4). Mol Med Rep (2016) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 图 5
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell signaling, 5023)被用于被用于免疫印迹在人类样本上 (图 5). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 3d
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 2772)被用于被用于免疫印迹在小鼠样本上 (图 3d). Stem Cells Dev (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 图 4f
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 2772)被用于被用于免疫印迹在大鼠样本上 (图 4f). Cell Mol Neurobiol (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 1
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, CS2772)被用于被用于免疫印迹在小鼠样本上 (图 1). Cell Death Differ (2016) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 图 4c, 5d
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell signaling, 5023)被用于被用于免疫印迹在人类样本上 (图 4c, 5d). PLoS ONE (2015) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 1:1000; 图 3c
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, D2E11)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3c). Mol Med Rep (2015) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 图 2
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell signaling, 5023)被用于被用于免疫印迹在人类样本上 (图 2). Pigment Cell Melanoma Res (2015) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 图 6
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(CST, 5023)被用于被用于免疫印迹在人类样本上 (图 6). Biomed Pharmacother (2015) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 图 6b
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, D2E11)被用于被用于免疫印迹在人类样本上 (图 6b). Cell Death Dis (2015) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 图 s3
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, D2E11)被用于被用于免疫印迹在人类样本上 (图 s3). Proc Natl Acad Sci U S A (2014) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 5023)被用于被用于免疫印迹在人类样本上. Oncogene (2015) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 5023)被用于被用于免疫印迹在人类样本上浓度为1:1000. PLoS ONE (2014) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 5023)被用于被用于免疫印迹在人类样本上. Cell Death Dis (2014) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 5023)被用于被用于免疫印迹在人类样本上. Redox Biol (2013) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 5023)被用于被用于免疫印迹在人类样本上. World J Gastroenterol (2013) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 5023)被用于被用于免疫印迹在人类样本上浓度为1:1000. Acta Pharmacol Sin (2013) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling Technology, 5023)被用于被用于免疫印迹在人类样本上. Mol Oncol (2013) ncbi
domestic rabbit 单克隆(D2E11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司B细胞淋巴瘤2相关的X蛋白抗体(Cell Signaling, 5023)被用于被用于免疫印迹在人类样本上. PLoS ONE (2013) ncbi
Bioworld
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:100; 图 4
BioworldB细胞淋巴瘤2相关的X蛋白抗体(Bioworld Technology, BS2538)被用于被用于免疫印迹在人类样本上浓度为1:100 (图 4). Oncol Lett (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:800; 图 6
BioworldB细胞淋巴瘤2相关的X蛋白抗体(Bio-World, bs2538)被用于被用于免疫印迹在大鼠样本上浓度为1:800 (图 6). Mol Med Rep (2016) ncbi
丹科医疗器械技术服务(上海)有限公司
domestic rabbit 多克隆
  • 免疫沉淀; 人类; 图 5
  • 免疫印迹; 人类; 图 1
丹科医疗器械技术服务(上海)有限公司B细胞淋巴瘤2相关的X蛋白抗体(Dako, A3533)被用于被用于免疫沉淀在人类样本上 (图 5) 和 被用于免疫印迹在人类样本上 (图 1). Cell Death Dis (2016) ncbi
碧迪BD
小鼠 单克隆(6A7)
  • 免疫印迹; 人类
碧迪BDB细胞淋巴瘤2相关的X蛋白抗体(BD Pharmingen, 556467)被用于被用于免疫印迹在人类样本上. Cell Death Differ (2020) ncbi
小鼠 单克隆(6A7)
  • 免疫印迹; 人类
碧迪BDB细胞淋巴瘤2相关的X蛋白抗体(BD Pharmingen, 556467)被用于被用于免疫印迹在人类样本上. Antioxidants (Basel) (2020) ncbi
小鼠 单克隆(6A7)
  • 流式细胞仪; 人类; 1:100
  • 免疫印迹; 人类; 图 4e
碧迪BDB细胞淋巴瘤2相关的X蛋白抗体(BD Biosciences, 556467)被用于被用于流式细胞仪在人类样本上浓度为1:100 和 被用于免疫印迹在人类样本上 (图 4e). Cell Death Differ (2017) ncbi
小鼠 单克隆(6A7)
  • 免疫沉淀; 人类; 图 4c
  • 免疫印迹; 人类; 图 4c
碧迪BDB细胞淋巴瘤2相关的X蛋白抗体(BD Biosciences, 556467)被用于被用于免疫沉淀在人类样本上 (图 4c) 和 被用于免疫印迹在人类样本上 (图 4c). Oncogene (2017) ncbi
小鼠 单克隆(3/Bax)
  • 免疫印迹; 人类; 图 4a
碧迪BDB细胞淋巴瘤2相关的X蛋白抗体(BD, 610982)被用于被用于免疫印迹在人类样本上 (图 4a). Stem Cells Int (2016) ncbi
小鼠 单克隆(3/Bax)
  • 流式细胞仪; 人类; 图 4d
碧迪BDB细胞淋巴瘤2相关的X蛋白抗体(Becton Dickinson, 3)被用于被用于流式细胞仪在人类样本上 (图 4d). Oncotarget (2017) ncbi
小鼠 单克隆(3/Bax)
  • 免疫印迹; 人类; 图 8
碧迪BDB细胞淋巴瘤2相关的X蛋白抗体(BD Biosciences, 610982)被用于被用于免疫印迹在人类样本上 (图 8). J Virol (2016) ncbi
小鼠 单克隆(3/Bax)
  • 免疫印迹; 大鼠; 1:1000; 图 2
碧迪BDB细胞淋巴瘤2相关的X蛋白抗体(BD Biosciences, 610983)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 2). Mol Med Rep (2016) ncbi
小鼠 单克隆(3/Bax)
  • 其他; 人类; 图 st1
碧迪BDB细胞淋巴瘤2相关的X蛋白抗体(BD, 3)被用于被用于其他在人类样本上 (图 st1). Mol Cell Proteomics (2016) ncbi
小鼠 单克隆(6A7)
  • 免疫细胞化学; 人类; 图 3a
碧迪BDB细胞淋巴瘤2相关的X蛋白抗体(BD Pharmingen, 6A7)被用于被用于免疫细胞化学在人类样本上 (图 3a). Oncotarget (2015) ncbi
小鼠 单克隆(6A7)
  • 免疫印迹; 大鼠; 图 10
碧迪BDB细胞淋巴瘤2相关的X蛋白抗体(Pharmingen, 556467)被用于被用于免疫印迹在大鼠样本上 (图 10). PLoS ONE (2015) ncbi
小鼠 单克隆(6A7)
  • 免疫沉淀; 人类
  • 免疫细胞化学; 人类; 图 4b
碧迪BDB细胞淋巴瘤2相关的X蛋白抗体(BD, 6A7)被用于被用于免疫沉淀在人类样本上 和 被用于免疫细胞化学在人类样本上 (图 4b). Cell Death Dis (2015) ncbi
小鼠 单克隆(6A7)
  • 免疫印迹; 人类; 1:500
碧迪BDB细胞淋巴瘤2相关的X蛋白抗体(BD Biosciences, 556467)被用于被用于免疫印迹在人类样本上浓度为1:500. Chem Biol Interact (2015) ncbi
小鼠 单克隆(6A7)
  • 免疫印迹; 人类
碧迪BDB细胞淋巴瘤2相关的X蛋白抗体(BD Pharmingen, 6A7)被用于被用于免疫印迹在人类样本上. Leuk Lymphoma (2014) ncbi
小鼠 单克隆(6A7)
  • 流式细胞仪; 人类
碧迪BDB细胞淋巴瘤2相关的X蛋白抗体(BD Pharmingen, 6A7)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2011) ncbi
西格玛奥德里奇
小鼠 单克隆(2D2)
  • 免疫印迹; 人类
西格玛奥德里奇B细胞淋巴瘤2相关的X蛋白抗体(Sigma, B8554)被用于被用于免疫印迹在人类样本上. Curr Mol Med (2014) ncbi
文章列表
  1. Wen S, Unuma K, Funakoshi T, Aki T, Uemura K. Contraction Band Necrosis with Dephosphorylated Connexin 43 in Rat Myocardium after Daily Cocaine Administration. Int J Mol Sci. 2022;23: pubmed 出版商
  2. Zang N, Cui C, Guo X, Song J, Hu H, Yang M, et al. cGAS-STING activation contributes to podocyte injury in diabetic kidney disease. iScience. 2022;25:105145 pubmed 出版商
  3. Fei X, Wu X, Dou Y, Sun K, Guo Q, Zhang L, et al. TRIM22 orchestrates the proliferation of GBMs and the benefits of TMZ by coordinating the modification and degradation of RIG-I. Mol Ther Oncolytics. 2022;26:413-428 pubmed 出版商
  4. Liu Y, Xu Y, Yao Y, Cao Y, Chen G, Cai Y, et al. I-κB kinase-ε deficiency improves doxorubicin-induced dilated cardiomyopathy by inhibiting the NF-κB pathway. Front Physiol. 2022;13:934899 pubmed 出版商
  5. Zhang Z, Li P, Sun P. Expression of SAMHD1 and its mutation on prognosis of colon cancer. Oncol Lett. 2022;24:303 pubmed 出版商
  6. Gao H, Sun H, Yan N, Zhao P, Xu H, Zheng W, et al. ATP13A2 Declines Zinc-Induced Accumulation of α-Synuclein in a Parkinson's Disease Model. Int J Mol Sci. 2022;23: pubmed 出版商
  7. Shu W, Zhu X, Wang K, Cherepanoff S, Conway R, Madigan M, et al. The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma. Cell Oncol (Dordr). 2022;45:601-619 pubmed 出版商
  8. Narayan S, Raza A, Mahmud I, Koo N, Garrett T, LAW M, et al. Sensitization of FOLFOX-resistant colorectal cancer cells via the modulation of a novel pathway involving protein phosphatase 2A. iScience. 2022;25:104518 pubmed 出版商
  9. Luo H, Song Y, Zhang J, Liu Y, Chen F, Wang Z, et al. MAT2A facilitates PDCD6 methylation and promotes cell growth under glucose deprivation in cervical cancer. Cell Death Discov. 2022;8:176 pubmed 出版商
  10. Zheng C, Xuan W, Chen Z, Zhang R, Huang X, Zhu Y, et al. CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome. Front Pharmacol. 2022;13:848310 pubmed 出版商
  11. He S, Gao Q, Wu X, Shi J, Zhang Y, Yang J, et al. NAD+ ameliorates endotoxin-induced acute kidney injury in a sirtuin1-dependent manner via GSK-3β/Nrf2 signalling pathway. J Cell Mol Med. 2022;26:1979-1993 pubmed 出版商
  12. Wu C, Wang Y, Hu S, Wu W, Yeh C, Bamodu O. MED10 Drives the Oncogenicity and Refractory Phenotype of Bladder Urothelial Carcinoma Through the Upregulation of hsa-miR-590. Front Oncol. 2021;11:744937 pubmed 出版商
  13. Liu W, Feng Q, Liao W, Li E, Wu L. TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a. J Cancer. 2021;12:6905-6920 pubmed 出版商
  14. Fang S, Sun S, Cai H, Zou X, Wang S, Hao X, et al. IRGM/Irgm1 facilitates macrophage apoptosis through ROS generation and MAPK signal transduction: Irgm1 +/- mice display increases atherosclerotic plaque stability. Theranostics. 2021;11:9358-9375 pubmed 出版商
  15. Cao Y, Li Q, Yang Y, Ke Z, Chen S, Li M, et al. Cardioprotective Effect of Stem-Leaf Saponins From Panax notoginseng on Mice With Sleep Derivation by Inhibiting Abnormal Autophagy Through PI3K/Akt/mTOR Pathway. Front Cardiovasc Med. 2021;8:694219 pubmed 出版商
  16. Gyamfi J, Yeo J, Kwon D, Min B, Cha Y, Koo J, et al. Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer. NPJ Breast Cancer. 2021;7:129 pubmed 出版商
  17. Tian N, Hu L, Lu Y, Tong L, Feng M, Liu Q, et al. TKT maintains intestinal ATP production and inhibits apoptosis-induced colitis. Cell Death Dis. 2021;12:853 pubmed 出版商
  18. Chiang C, Hong Y. In situ delivery of biobutyrate by probiotic Escherichia coli for cancer therapy. Sci Rep. 2021;11:18172 pubmed 出版商
  19. Huang J, Xiao R, Wang X, Khadka B, Fang Z, Yu M, et al. MicroRNA‑93 knockdown inhibits acute myeloid leukemia cell growth via inactivating the PI3K/AKT pathway by upregulating DAB2. Int J Oncol. 2021;59: pubmed 出版商
  20. Zuo Y, Xie J, Li X, Li Y, Thirupathi A, Zhang J, et al. Ferritinophagy-Mediated Ferroptosis Involved in Paraquat-Induced Neurotoxicity of Dopaminergic Neurons: Implication for Neurotoxicity in PD. Oxid Med Cell Longev. 2021;2021:9961628 pubmed 出版商
  21. Liu W, Long Q, Zhang W, Zeng D, Hu B, Liu S, et al. miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/JAK2/STAT3 axis. Aging (Albany NY). 2021;13:19760-19775 pubmed 出版商
  22. Yan D, Li X, Yang Q, Huang Q, Yao L, Zhang P, et al. Regulation of Bax-dependent apoptosis by mitochondrial deubiquitinase USP30. Cell Death Discov. 2021;7:211 pubmed 出版商
  23. Zheleznyak A, Mixdorf M, Marsala L, Prior J, Yang X, Cui G, et al. Orthogonal targeting of osteoclasts and myeloma cells for radionuclide stimulated dynamic therapy induces multidimensional cell death pathways. Theranostics. 2021;11:7735-7754 pubmed 出版商
  24. Meng L, Zhang Y, Li D, Shang X, Hao X, Chen X, et al. TIMP3 attenuates cerebral ischemia/reperfusion-induced apoptosis and oxidative stress in neurocytes by regulating the AKT pathway. Exp Ther Med. 2021;22:973 pubmed 出版商
  25. Lassiter R, Merchen T, Fang X, Wang Y. Protective Role of Kynurenine 3-Monooxygenase in Allograft Rejection and Tubular Injury in Kidney Transplantation. Front Immunol. 2021;12:671025 pubmed 出版商
  26. Gao L, Meng J, Yue C, Wu X, Su Q, Wu H, et al. Integrative analysis the characterization of peroxiredoxins in pan-cancer. Cancer Cell Int. 2021;21:366 pubmed 出版商
  27. Yue Z, Jiang Z, Ruan B, Duan J, Song P, Liu J, et al. Disruption of myofibroblastic Notch signaling attenuates liver fibrosis by modulating fibrosis progression and regression. Int J Biol Sci. 2021;17:2135-2146 pubmed 出版商
  28. Cho J, Lee J, Kim H, Lee H, Fang Z, Kwon H, et al. Ethyl Acetate Fraction of Amomum villosum var. xanthioides Attenuates Hepatic Endoplasmic Reticulum Stress-Induced Non-Alcoholic Steatohepatitis via Improvement of Antioxidant Capacities. Antioxidants (Basel). 2021;10: pubmed 出版商
  29. Zou S, Gao Y, Zhang S. lncRNA HCP5 acts as a ceRNA to regulate EZH2 by sponging miR‑138‑5p in cutaneous squamous cell carcinoma. Int J Oncol. 2021;59: pubmed 出版商
  30. Zhang Y, Ding L, Ni Q, Tao R, Qin J. Transcription factor PAX4 facilitates gastric cancer progression through interacting with miR-27b-3p/Grb2 axis. Aging (Albany NY). 2021;13:16786-16803 pubmed 出版商
  31. Bai Y, Pei W, Zhang X, Zheng H, Hua C, Min J, et al. ApoM is an important potential protective factor in the pathogenesis of primary liver cancer. J Cancer. 2021;12:4661-4671 pubmed 出版商
  32. Chen F, Han J, Wang D. Identification of key microRNAs and the underlying molecular mechanism in spinal cord ischemia-reperfusion injury in rats. Peerj. 2021;9:e11454 pubmed 出版商
  33. Basse A, Agerholm M, Farup J, Dalbram E, Nielsen J, Ørtenblad N, et al. Nampt controls skeletal muscle development by maintaining Ca2+ homeostasis and mitochondrial integrity. Mol Metab. 2021;53:101271 pubmed 出版商
  34. Mou S, Zhou Z, Feng H, Zhang N, Lin Z, Aiyasiding X, et al. Liquiritin Attenuates Lipopolysaccharides-Induced Cardiomyocyte Injury via an AMP-Activated Protein Kinase-Dependent Signaling Pathway. Front Pharmacol. 2021;12:648688 pubmed 出版商
  35. Hong H, Jin Z, Qian T, Xu X, Zhu X, Fei Q, et al. Falcarindiol Enhances Cisplatin Chemosensitivity of Hepatocellular Carcinoma via Down-Regulating the STAT3-Modulated PTTG1 Pathway. Front Pharmacol. 2021;12:656697 pubmed 出版商
  36. Li Q, Liu M, Sun Y, Jin T, Zhu P, Wan X, et al. SLC6A8-mediated intracellular creatine accumulation enhances hypoxic breast cancer cell survival via ameliorating oxidative stress. J Exp Clin Cancer Res. 2021;40:168 pubmed 出版商
  37. Liu Y, Cong P, Zhang T, Wang R, Wang X, Liu J, et al. Plasmalogen attenuates the development of hepatic steatosis and cognitive deficit through mechanism involving p75NTR inhibition. Redox Biol. 2021;43:102002 pubmed 出版商
  38. Hu J, Wang J, Li C, Shang Y. Fructose-1,6-bisphosphatase aggravates oxidative stress-induced apoptosis in asthma by suppressing the Nrf2 pathway. J Cell Mol Med. 2021;25:5001-5014 pubmed 出版商
  39. Liu Y, Xu S, Zhang H, Qian K, Huang J, Gu X, et al. Stimulation of α7-nAChRs coordinates autophagy and apoptosis signaling in experimental knee osteoarthritis. Cell Death Dis. 2021;12:448 pubmed 出版商
  40. Yu F, Ma R, Liu C, Zhang L, Feng K, Wang M, et al. SQSTM1/p62 Promotes Cell Growth and Triggers Autophagy in Papillary Thyroid Cancer by Regulating the AKT/AMPK/mTOR Signaling Pathway. Front Oncol. 2021;11:638701 pubmed 出版商
  41. Chen X, Ma W, Yao Y, Zhang Q, Li J, Wu X, et al. Serum deprivation-response protein induces apoptosis in hepatocellular carcinoma through ASK1-JNK/p38 MAPK pathways. Cell Death Dis. 2021;12:425 pubmed 出版商
  42. Loureiro J, Raimundo L, Calheiros J, Carvalho C, Barcherini V, Lima N, et al. Targeting p53 for Melanoma Treatment: Counteracting Tumour Proliferation, Dissemination and Therapeutic Resistance. Cancers (Basel). 2021;13: pubmed 出版商
  43. Zhou H, Li G, Wang Y, Jiang R, Li Y, Wang H, et al. Microbial Metabolite Sodium Butyrate Attenuates Cartilage Degradation by Restoring Impaired Autophagy and Autophagic Flux in Osteoarthritis Development. Front Pharmacol. 2021;12:659597 pubmed 出版商
  44. Guo J, Zhu H, Li Q, Dong J, Xiong W, Yu K. SPRY4 suppresses proliferation and induces apoptosis of colorectal cancer cells by repressing oncogene EZH2. Aging (Albany NY). 2021;13:11665-11677 pubmed 出版商
  45. Low H, Wong Z, Wu B, Kong L, Png C, Cho Y, et al. DUSP16 promotes cancer chemoresistance through regulation of mitochondria-mediated cell death. Nat Commun. 2021;12:2284 pubmed 出版商
  46. Tian Y, Zhang M, Zhao A, Kong L, Wang J, Shen W, et al. Single-cell transcriptomic profiling provides insights into the toxic effects of Zearalenone exposure on primordial follicle assembly. Theranostics. 2021;11:5197-5213 pubmed 出版商
  47. Cao X, Ma Q, Wang B, Qian Q, Liu N, Liu T, et al. Silencing long non-coding RNA MIAT ameliorates myocardial dysfunction induced by myocardial infarction via MIAT/miR-10a-5p/EGR2 axis. Aging (Albany NY). 2021;13:11188-11206 pubmed 出版商
  48. Liu X, Zhang H, Zhou P, Yu Y, Zhang H, Chen L, et al. CREB1 acts via the miR‑922/ARID2 axis to enhance malignant behavior of liver cancer cells. Oncol Rep. 2021;45: pubmed 出版商
  49. Yin S, Li L, Tao Y, Yu J, Wei S, Liu M, et al. The Inhibitory Effect of Artesunate on Excessive Endoplasmic Reticulum Stress Alleviates Experimental Colitis in Mice. Front Pharmacol. 2021;12:629798 pubmed 出版商
  50. Kim D, Park J, Choi H, Kim C, Bae E, Ma S, et al. The critical role of FXR is associated with the regulation of autophagy and apoptosis in the progression of AKI to CKD. Cell Death Dis. 2021;12:320 pubmed 出版商
  51. Jin X, Zhu L, Xiao S, Cui Z, Tang J, Yu J, et al. MST1 inhibits the progression of breast cancer by regulating the Hippo signaling pathway and may serve as a prognostic biomarker. Mol Med Rep. 2021;23: pubmed 出版商
  52. Chen W, Wu C, Chen Y, Guo Y, Qiu L, Liu Z, et al. Downregulation of ceramide synthase 1 promotes oral cancer through endoplasmic reticulum stress. Int J Oral Sci. 2021;13:10 pubmed 出版商
  53. Zhou M, Wang X, Shi Y, Ding Y, Li X, Xie T, et al. Deficiency of ITGAM Attenuates Experimental Abdominal Aortic Aneurysm in Mice. J Am Heart Assoc. 2021;10:e019900 pubmed 出版商
  54. Shen Z, Ji K, Cai Z, Huang C, He X, Xu H, et al. Inhibition of HDAC6 by Tubastatin A reduces chondrocyte oxidative stress in chondrocytes and ameliorates mouse osteoarthritis by activating autophagy. Aging (Albany NY). 2021;13:9820-9837 pubmed 出版商
  55. An J, Yang J, Yao Y, Lu K, Zhao Z, Yu M, et al. Sirtuin 6 regulates the proliferation and survival of clear cell renal cell carcinoma cells via B-cell lymphoma 2. Oncol Lett. 2021;21:293 pubmed 出版商
  56. Xu J, Ma L, Fu P. Eriocitrin attenuates ischemia reperfusion-induced oxidative stress and inflammation in rats with acute kidney injury by regulating the dual-specificity phosphatase 14 (DUSP14)-mediated Nrf2 and nuclear factor-κB (NF-κB) pathways. Ann Transl Med. 2021;9:350 pubmed 出版商
  57. Fang Y, Jiang Q, Li S, Zhu H, Xu R, Song N, et al. Opposing functions of β-arrestin 1 and 2 in Parkinson's disease via microglia inflammation and Nprl3. Cell Death Differ. 2021;28:1822-1836 pubmed 出版商
  58. Wu N, Du X, Peng Z, Zhang Z, Cui L, Li D, et al. Silencing of peroxiredoxin 1 expression ameliorates ulcerative colitis in a rat model. J Int Med Res. 2021;49:300060520986313 pubmed 出版商
  59. Nagamura Y, Miyazaki M, Nagano Y, Yuki M, Fukami K, Yanagihara K, et al. PLEKHA5 regulates the survival and peritoneal dissemination of diffuse-type gastric carcinoma cells with Met gene amplification. Oncogenesis. 2021;10:25 pubmed 出版商
  60. Liu J, Wang C, Cheng T, Rixiati Y, Ji C, Deng M, et al. Circadian Clock Disruption Suppresses PDL1+ Intraepithelial B Cells in Experimental Colitis and Colitis-Associated Colorectal Cancer. Cell Mol Gastroenterol Hepatol. 2021;12:251-276 pubmed 出版商
  61. Xiao Z, Yang X, Liu Z, Shao Z, Song C, Zhang K, et al. GASC1 promotes glioma progression by enhancing NOTCH1 signaling. Mol Med Rep. 2021;23: pubmed 出版商
  62. Cheng Y, Liu M, Tang H, Chen B, Yang G, Zhao W, et al. iTRAQ-Based Quantitative Proteomics Indicated Nrf2/OPTN-Mediated Mitophagy Inhibits NLRP3 Inflammasome Activation after Intracerebral Hemorrhage. Oxid Med Cell Longev. 2021;2021:6630281 pubmed 出版商
  63. Cao Y, Li L, Liu Y, Chen G, Tao Z, Wang R, et al. I-κB Kinase-ε Deficiency Attenuates the Development of Angiotensin II-Induced Myocardial Hypertrophy in Mice. Oxid Med Cell Longev. 2021;2021:6429197 pubmed 出版商
  64. Xu Y, Li D, Wu J, Zhang M, Shao X, Xu L, et al. Farnesoid X receptor promotes renal ischaemia-reperfusion injury by inducing tubular epithelial cell apoptosis. Cell Prolif. 2021;54:e13005 pubmed 出版商
  65. Shen X, Wang H, Weng C, Jiang H, Chen J. Caspase 3/GSDME-dependent pyroptosis contributes to chemotherapy drug-induced nephrotoxicity. Cell Death Dis. 2021;12:186 pubmed 出版商
  66. Nozaki Y, Hikita H, Tanaka S, Fukumoto K, Urabe M, Sato K, et al. Persistent hepatocyte apoptosis promotes tumorigenesis from diethylnitrosamine-transformed hepatocytes through increased oxidative stress, independent of compensatory liver regeneration. Sci Rep. 2021;11:3363 pubmed 出版商
  67. Dowling C, Hollinshead K, Di Grande A, Pritchard J, Zhang H, Dillon E, et al. Multiple screening approaches reveal HDAC6 as a novel regulator of glycolytic metabolism in triple-negative breast cancer. Sci Adv. 2021;7: pubmed 出版商
  68. Chen F, Xu B, Li J, Yang X, Gu J, Yao X, et al. Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma via KLF10. J Exp Clin Cancer Res. 2021;40:38 pubmed 出版商
  69. Saiyang X, QingQing W, Man X, Chen L, Min Z, Yun X, et al. Activation of Toll-like receptor 7 provides cardioprotection in septic cardiomyopathy-induced systolic dysfunction. Clin Transl Med. 2021;11:e266 pubmed 出版商
  70. Li S, Zhu Z, Xue M, Pan X, Tong G, Yi X, et al. The protective effects of fibroblast growth factor 10 against hepatic ischemia-reperfusion injury in mice. Redox Biol. 2021;40:101859 pubmed 出版商
  71. Deng X, He Y, Miao X, Yu B. ATF4-mediated histone deacetylase HDAC1 promotes the progression of acute pancreatitis. Cell Death Dis. 2021;12:5 pubmed 出版商
  72. Wen Y, Hou Y, Yi X, Sun S, Guo J, He X, et al. EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells. Theranostics. 2021;11:1795-1813 pubmed 出版商
  73. Liu M, Li W, Song F, Zhang L, Sun X. Silencing of lncRNA MIAT alleviates LPS-induced pneumonia via regulating miR-147a/NKAP/NF-κB axis. Aging (Albany NY). 2020;13:2506-2518 pubmed 出版商
  74. Liang X, Yan Z, Ma W, Qian Y, Zou X, Cui Y, et al. Peroxiredoxin 4 protects against ovarian ageing by ameliorating D-galactose-induced oxidative damage in mice. Cell Death Dis. 2020;11:1053 pubmed 出版商
  75. Xiao L, Zhong M, Huang Y, Zhu J, Tang W, Li D, et al. Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6/ROS-dependent MAPK/NF-κB signaling pathways. Aging (Albany NY). 2020;12:21706-21729 pubmed 出版商
  76. Chen Z, Zhou Q, Liu C, Zeng Y, Yuan S. Klotho deficiency aggravates diabetes-induced podocyte injury due to DNA damage caused by mitochondrial dysfunction. Int J Med Sci. 2020;17:2763-2772 pubmed 出版商
  77. Sun Q, Chen J, Xu L, Kang J, Wu X, Ren Y, et al. MUTYH Deficiency Is Associated with Attenuated Pulmonary Fibrosis in a Bleomycin-Induced Model. Oxid Med Cell Longev. 2020;2020:4828256 pubmed 出版商
  78. Omairi I, Kobeissy F, Nasreddine S. Anti-Oxidant, Anti-Hemolytic Effects of Crataegus aronia Leaves and Its Anti- Proliferative Effect Enhance Cisplatin Cytotoxicity in A549 Human Lung Cancer Cell Line. Asian Pac J Cancer Prev. 2020;21:2993-3003 pubmed 出版商
  79. Tang S, Wu W, Wan H, Wu X, Chen H. Knockdown of NHP2 inhibits hepatitis B virus X protein-induced hepatocarcinogenesis via repressing TERT expression and disrupting the stability of telomerase complex. Aging (Albany NY). 2020;12:19365-19374 pubmed 出版商
  80. Zhang Y, Zhang L, Lu S, Xiang Y, Zeng C, He T, et al. Long Non-coding RNA CASC15 Promotes Intrahepatic Cholangiocarcinoma Possibly through Inducing PRDX2/PI3K/AKT Axis. Cancer Res Treat. 2021;53:184-198 pubmed 出版商
  81. Wang T, Gao X, Zhou K, Jiang T, Gao S, Liu P, et al. Role of ARID1A in epithelial‑mesenchymal transition in breast cancer and its effect on cell sensitivity to 5‑FU. Int J Mol Med. 2020;46:1683-1694 pubmed 出版商
  82. He S, Fang X, Xia X, Hou T, Zhang T. Targeting CDK9: A novel biomarker in the treatment of endometrial cancer. Oncol Rep. 2020;44:1929-1938 pubmed 出版商
  83. Chen J, Liu X, Ke K, Zou J, Gao Z, Habuchi T, et al. LINC00992 contributes to the oncogenic phenotypes in prostate cancer via targeting miR-3935 and augmenting GOLM1 expression. BMC Cancer. 2020;20:749 pubmed 出版商
  84. Au C, Furness J, Britt K, Oshchepkova S, Ladumor H, Soo K, et al. Three-dimensional growth of breast cancer cells potentiates the anti-tumor effects of unacylated ghrelin and AZP-531. elife. 2020;9: pubmed 出版商
  85. Gu J, Zhang Y, Wang X, Xiang J, Deng S, Wu D, et al. Matrine inhibits the growth of natural killer/T-cell lymphoma cells by modulating CaMKIIγ-c-Myc signaling pathway. BMC Complement Med Ther. 2020;20:214 pubmed 出版商
  86. Yin S, Song M, Zhao R, Liu X, Kang W, Lee J, et al. Xanthohumol Inhibits the Growth of Keratin 18-Overexpressed Esophageal Squamous Cell Carcinoma in vitro and in vivo. Front Cell Dev Biol. 2020;8:366 pubmed 出版商
  87. Liu Y, Jiang B, Cao Y, Chen W, Yin L, Xu Y, et al. High expression levels and localization of Sox5 in dilated cardiomyopathy. Mol Med Rep. 2020;22:948-956 pubmed 出版商
  88. Vu M, Kassouf N, Ofili R, Lund T, Bell C, Appiah S. Doxorubicin selectively induces apoptosis through the inhibition of a novel isoform of Bcl‑2 in acute myeloid leukaemia MOLM‑13 cells with reduced Beclin 1 expression. Int J Oncol. 2020;57:113-121 pubmed 出版商
  89. Simula L, Corrado M, Accordi B, Di Rita A, Nazio F, Antonucci Y, et al. JNK1 and ERK1/2 modulate lymphocyte homeostasis via BIM and DRP1 upon AICD induction. Cell Death Differ. 2020;: pubmed 出版商
  90. Tibaldi E, Federti E, Matte A, Iatcenko I, Wilson A, Riccardi V, et al. Oxidation Impacts the Intracellular Signaling Machinery in Hematological Disorders. Antioxidants (Basel). 2020;9: pubmed 出版商
  91. Edwards G, Perkins G, Kim K, Kong Y, Lee Y, Choi S, et al. Loss of AKAP1 triggers Drp1 dephosphorylation-mediated mitochondrial fission and loss in retinal ganglion cells. Cell Death Dis. 2020;11:254 pubmed 出版商
  92. Zhao J, Li G, Zhao X, Lin X, Gao Y, Raimundo N, et al. Down-regulation of AMPK signaling pathway rescues hearing loss in TFB1 transgenic mice and delays age-related hearing loss. Aging (Albany NY). 2020;12:5590-5611 pubmed 出版商
  93. Feng C, Zhang H, Zeng A, Bai M, Wang X. Tumor-Suppressive MicroRNA-216b Binds to TPX2, Activating the p53 Signaling in Human Cutaneous Squamous Cell Carcinoma. Mol Ther Nucleic Acids. 2020;20:186-195 pubmed 出版商
  94. Guo Y, Zhang Z, Wang Z, Liu G, Liu Y, Wang H. Astragalus polysaccharides inhibit ovarian cancer cell growth via microRNA-27a/FBXW7 signaling pathway. Biosci Rep. 2020;40: pubmed 出版商
  95. Bajpai R, Sharma A, Achreja A, Edgar C, Wei C, Siddiqa A, et al. Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma. Nat Commun. 2020;11:1228 pubmed 出版商
  96. Gao Y, Dai X, Li Y, Li G, Lin X, Ai C, et al. Role of Parkin-mediated mitophagy in the protective effect of polydatin in sepsis-induced acute kidney injury. J Transl Med. 2020;18:114 pubmed 出版商
  97. Xiang Q, Kang L, Wang J, Liao Z, Song Y, Zhao K, et al. CircRNA-CIDN mitigated compression loading-induced damage in human nucleus pulposus cells via miR-34a-5p/SIRT1 axis. EBioMedicine. 2020;53:102679 pubmed 出版商
  98. Zhuang K, Zuo Y, Sherchan P, Wang J, Yan X, Liu F. Hydrogen Inhalation Attenuates Oxidative Stress Related Endothelial Cells Injury After Subarachnoid Hemorrhage in Rats. Front Neurosci. 2019;13:1441 pubmed 出版商
  99. Xiang S, Chen K, Xu L, Wang T, Guo C. Bergenin Exerts Hepatoprotective Effects by Inhibiting the Release of Inflammatory Factors, Apoptosis and Autophagy via the PPAR-γ Pathway. Drug Des Devel Ther. 2020;14:129-143 pubmed 出版商
  100. Hou K, Li G, Zhao J, Xu B, Zhang Y, Yu J, et al. Bone mesenchymal stem cell-derived exosomal microRNA-29b-3p prevents hypoxic-ischemic injury in rat brain by activating the PTEN-mediated Akt signaling pathway. J Neuroinflammation. 2020;17:46 pubmed 出版商
  101. Jiang L, Xu K, Li J, Zhou X, Xu L, Wu Z, et al. Nesfatin-1 suppresses interleukin-1β-induced inflammation, apoptosis, and cartilage matrix destruction in chondrocytes and ameliorates osteoarthritis in rats. Aging (Albany NY). 2020;12:1760-1777 pubmed 出版商
  102. Cui J, Duan J, Chu J, Guo C, Xi M, Li Y, et al. Chikusetsu saponin IVa protects pancreatic β cell against intermittent high glucose-induced injury by activating Wnt/β-catenin/TCF7L2 pathway. Aging (Albany NY). 2020;12:1591-1609 pubmed 出版商
  103. Li C, Liu W, Li X, Zhang Z, Qi H, Liu S, et al. The novel GLP-1/GIP analogue DA5-CH reduces tau phosphorylation and normalizes theta rhythm in the icv. STZ rat model of AD. Brain Behav. 2020;10:e01505 pubmed 出版商
  104. Molagoda I, Lee K, Choi Y, Kim G. Anthocyanins from Hibiscus syriacus L. Inhibit Oxidative Stress-Mediated Apoptosis by Activating the Nrf2/HO-1 Signaling Pathway. Antioxidants (Basel). 2020;9: pubmed 出版商
  105. Sheng L, Zhang J, Li L, Xie X, Wen X, Cheng K. Design, Synthesis, and Evaluation of Novel 2-Methoxyestradiol Derivatives as Apoptotic Inducers Through an Intrinsic Apoptosis Pathway. Biomolecules. 2020;10: pubmed 出版商
  106. Chen X, Zhao Y, Xu J, Bao J, Zhao J, Chen J, et al. The Nephroprotective Effect of TNF Receptor-Associated Factor 6 (TRAF6) Blockade on LPS-Induced Acute Renal Injury Through the Inhibition if Inflammation and Oxidative Stress. Med Sci Monit. 2020;26:e919698 pubmed 出版商
  107. Modi J, Menzie Suderam J, Xu H, Trujillo P, Medley K, Marshall M, et al. Mode of action of granulocyte-colony stimulating factor (G-CSF) as a novel therapy for stroke in a mouse model. J Biomed Sci. 2020;27:19 pubmed 出版商
  108. Shen S, Dean D, Yu Z, Hornicek F, Kan Q, Duan Z. Aberrant CDK9 expression within chordoma tissues and the therapeutic potential of a selective CDK9 inhibitor LDC000067. J Cancer. 2020;11:132-141 pubmed 出版商
  109. Tang L, Li J, Fu W, Wu W, Xu J. Suppression of FADS1 induces ROS generation, cell cycle arrest, and apoptosis in melanocytes: implications for vitiligo. Aging (Albany NY). 2019;11:11829-11843 pubmed 出版商
  110. Hu Y, Ma Y, Liu J, Cai Y, Zhang M, Fang X. LINC01128 expedites cervical cancer progression by regulating miR-383-5p/SFN axis. BMC Cancer. 2019;19:1157 pubmed 出版商
  111. Tian M, Gong W, Guo J. Long non-coding RNA SNHG1 indicates poor prognosis and facilitates disease progression in acute myeloid leukemia. Biol Open. 2019;8: pubmed 出版商
  112. Garc a Arroyo F, Monroy S nchez F, Mu oz Jim nez I, Gonzaga G, Andr s Hernando A, Zazueta C, et al. Allopurinol Prevents the Lipogenic Response Induced by an Acute Oral Fructose Challenge in Short-Term Fructose Fed Rats. Biomolecules. 2019;9: pubmed 出版商
  113. Liu J, Yao L, Zhang M, Jiang J, Yang M, Wang Y. Downregulation of LncRNA-XIST inhibited development of non-small cell lung cancer by activating miR-335/SOD2/ROS signal pathway mediated pyroptotic cell death. Aging (Albany NY). 2019;11:7830-7846 pubmed 出版商
  114. Chollat Namy M, Ben Safta Saadoun T, Haferssas D, Meurice G, Chouaib S, Thiery J. The pharmalogical reactivation of p53 function improves breast tumor cell lysis by granzyme B and NK cells through induction of autophagy. Cell Death Dis. 2019;10:695 pubmed 出版商
  115. Yan P, Su Z, Zhang Z, Gao T. LncRNA NEAT1 enhances the resistance of anaplastic thyroid carcinoma cells to cisplatin by sponging miR‑9‑5p and regulating SPAG9 expression. Int J Oncol. 2019;55:988-1002 pubmed 出版商
  116. Thangaraj K, Balasubramanian B, Park S, Natesan K, Liu W, Manju V. Orientin Induces G0/G1 Cell Cycle Arrest and Mitochondria Mediated Intrinsic Apoptosis in Human Colorectal Carcinoma HT29 Cells. Biomolecules. 2019;9: pubmed 出版商
  117. Gao L, Wang Z, Lu D, Huang J, Liu J, Hong L. Paeonol induces cytoprotective autophagy via blocking the Akt/mTOR pathway in ovarian cancer cells. Cell Death Dis. 2019;10:609 pubmed 出版商
  118. Zhang X, Du K, Lou Z, Ding K, Zhang F, Zhu J, et al. The CtBP1-HDAC1/2-IRF1 transcriptional complex represses the expression of the long noncoding RNA GAS5 in human osteosarcoma cells. Int J Biol Sci. 2019;15:1460-1471 pubmed 出版商
  119. Zierhut C, Yamaguchi N, Paredes M, Luo J, Carroll T, Funabiki H. The Cytoplasmic DNA Sensor cGAS Promotes Mitotic Cell Death. Cell. 2019;178:302-315.e23 pubmed 出版商
  120. Sun B, Zhao X, Ming J, Liu X, Liu D, Jiang C. Stepwise detection and evaluation reveal miR-10b and miR-222 as a remarkable prognostic pair for glioblastoma. Oncogene. 2019;38:6142-6157 pubmed 出版商
  121. Wang X, Peng P, Pan Z, Fang Z, Lu W, Liu X. Psoralen inhibits malignant proliferation and induces apoptosis through triggering endoplasmic reticulum stress in human SMMC7721 hepatoma cells. Biol Res. 2019;52:34 pubmed 出版商
  122. Kaur S, Nag A, Gangenahalli G, Sharma K. Peroxisome Proliferator Activated Receptor Gamma Sensitizes Non-small Cell Lung Carcinoma to Gamma Irradiation Induced Apoptosis. Front Genet. 2019;10:554 pubmed 出版商
  123. Suo L, Chang X, Xu N, Ji H. The Anti-proliferative Activity of GnRH Through Downregulation of the Akt/ERK Pathways in Pancreatic Cancer. Front Endocrinol (Lausanne). 2019;10:370 pubmed 出版商
  124. Liu F, Fan D, Yang Z, Tang N, Guo Z, Ma S, et al. TLR9 is essential for HMGB1-mediated post-myocardial infarction tissue repair through affecting apoptosis, cardiac healing, and angiogenesis. Cell Death Dis. 2019;10:480 pubmed 出版商
  125. Hou N, He X, Yang Y, Fu J, Zhang W, Guo Z, et al. TRPV1 Induced Apoptosis of Colorectal Cancer Cells by Activating Calcineurin-NFAT2-p53 Signaling Pathway. Biomed Res Int. 2019;2019:6712536 pubmed 出版商
  126. Loh J, Xu S, Huo J, Kim S, Wang Y, Lam K. Dok3-protein phosphatase 1 interaction attenuates Card9 signaling and neutrophil-dependent antifungal immunity. J Clin Invest. 2019;129:2717-2729 pubmed 出版商
  127. Donadoni M, Cicalese S, Sarkar D, Chang S, Sariyer I. Alcohol exposure alters pre-mRNA splicing of antiapoptotic Mcl-1L isoform and induces apoptosis in neural progenitors and immature neurons. Cell Death Dis. 2019;10:447 pubmed 出版商
  128. Wu K, Zou J, Lin C, Jie Z. MicroRNA-140-5p inhibits cell proliferation, migration and promotes cell apoptosis in gastric cancer through the negative regulation of THY1-mediated Notch signaling. Biosci Rep. 2019;: pubmed 出版商
  129. Li Z, Zhang S, Li J, Zeng H, Wang Y, Huang Y. Nerve regeneration in rat peripheral nerve allografts: Evaluation of cold-inducible RNA-binding protein in nerve storage and regeneration. J Comp Neurol. 2019;527:2885-2895 pubmed 出版商
  130. Nakai A, Fujimoto J, Miyata H, Stumm R, Narazaki M, Schulz S, et al. The COMMD3/8 complex determines GRK6 specificity for chemoattractant receptors. J Exp Med. 2019;: pubmed 出版商
  131. Pan C, Jin L, Wang X, Li Y, Chun J, Boese A, et al. Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance. J Clin Invest. 2019;129:2431-2445 pubmed 出版商
  132. Zhao J, Sun H, Zhang J, Wang M, Du X, Zhang J. Long non-coding RNA ANRIL down-regulates microRNA-7 to protect human trabecular meshwork cells in an experimental model for glaucoma. Eur Rev Med Pharmacol Sci. 2019;23:3173-3182 pubmed 出版商
  133. Zhang C, Zhu Q, Gu J, Chen S, Li Q, Ying L. Down-regulation of CCNE1 expression suppresses cell proliferation and sensitizes gastric carcinoma cells to Cisplatin. Biosci Rep. 2019;39: pubmed 出版商
  134. You Y, Qin Z, Zhang H, Yuan Z, Yu X. MicroRNA-153 promotes brain-derived neurotrophic factor and hippocampal neuron proliferation to alleviate autism symptoms through inhibition of JAK-STAT pathway by LEPR. Biosci Rep. 2019;: pubmed 出版商
  135. Liu X, Chen H, Hou Y, Ma X, Ye M, Huang R, et al. Adaptive EGF expression sensitizes pancreatic cancer cells to ionizing radiation through activation of the cyclin D1/P53/PARP pathway. Int J Oncol. 2019;54:1466-1480 pubmed 出版商
  136. Yu C, Li C, Chen I, Lai M, Lin Z, Korla P, et al. YWHAZ amplification/overexpression defines aggressive bladder cancer and contributes to chemo-/radio-resistance by suppressing caspase-mediated apoptosis. J Pathol. 2019;248:476-487 pubmed 出版商
  137. Rong X, Rao J, Li D, Jing Q, Lu Y, Ji Y. TRIM69 inhibits cataractogenesis by negatively regulating p53. Redox Biol. 2019;22:101157 pubmed 出版商
  138. Song C, Zhang J, Qi S, Liu Z, Zhang X, Zheng Y, et al. Cardiolipin remodeling by ALCAT1 links mitochondrial dysfunction to Parkinson's diseases. Aging Cell. 2019;18:e12941 pubmed 出版商
  139. Yan M, Wang J, Ren Y, Li L, He W, Zhang Y, et al. Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization. Cell Death Dis. 2019;10:204 pubmed 出版商
  140. Li K, Meng Z, Jiang L, Xia C, Xu K, Yuan D, et al. CDKL1 promotes the chemoresistance of human oral squamous cell carcinoma cells to hydroxycamptothecin. Mol Cell Probes. 2019;44:57-62 pubmed 出版商
  141. Li J, Liu X, Chen H, Sun Z, Chen H, Wang L, et al. Multi-targeting chemoprevention of Chinese herb formula Yanghe Huayan decoction on experimentally induced mammary tumorigenesis. BMC Complement Altern Med. 2019;19:48 pubmed 出版商
  142. Su W, Wang Y, Wang F, Zhang B, Zhang H, Shen Y, et al. Circular RNA hsa_circ_0007059 indicates prognosis and influences malignant behavior via AKT/mTOR in oral squamous cell carcinoma. J Cell Physiol. 2019;: pubmed 出版商
  143. Yuan Z, Zhang H, Hasnat M, Ding J, Chen X, Liang P, et al. A new perspective of triptolide-associated hepatotoxicity: Liver hypersensitivity upon LPS stimulation. Toxicology. 2019;414:45-56 pubmed 出版商
  144. Zhang J, Sheng J, Dong L, Xu Y, Yu L, Liu Y, et al. Cardiomyocyte-specific loss of RMP causes myocardial dysfunction and heart failure. Cardiovasc Res. 2018;: pubmed 出版商
  145. Liang C, Ma Y, Yong L, Yang C, Wang P, Liu X, et al. Y-box binding protein-1 promotes tumorigenesis and progression via the epidermal growth factor receptor/AKT pathway in spinal chordoma. Cancer Sci. 2019;110:166-179 pubmed 出版商
  146. Li H, Feng J, Zhang Y, Feng J, Wang Q, Zhao S, et al. Mst1 deletion attenuates renal ischaemia-reperfusion injury: The role of microtubule cytoskeleton dynamics, mitochondrial fission and the GSK3β-p53 signalling pathway. Redox Biol. 2019;20:261-274 pubmed 出版商
  147. De R, Sarkar S, Mazumder S, Debsharma S, Siddiqui A, Saha S, et al. Macrophage migration inhibitory factor regulates mitochondrial dynamics and cell growth of human cancer cell lines through CD74-NF-κB signaling. J Biol Chem. 2018;293:19740-19760 pubmed 出版商
  148. Luff S, Kao C, Papoutsakis E. Role of p53 and transcription-independent p53-induced apoptosis in shear-stimulated megakaryocytic maturation, particle generation, and platelet biogenesis. PLoS ONE. 2018;13:e0203991 pubmed 出版商
  149. Lee E, Ouzounova M, Piranlioglu R, Ma M, Guzel M, Marasco D, et al. The pleiotropic effects of TNFα in breast cancer subtypes is regulated by TNFAIP3/A20. Oncogene. 2019;38:469-482 pubmed 出版商
  150. Yang M, Li C, Zhu S, Cao L, Kroemer G, Zeh H, et al. TFAM is a novel mediator of immunogenic cancer cell death. Oncoimmunology. 2018;7:e1431086 pubmed 出版商
  151. Pan B, Wu L, Pan L, Yang Y, Li H, Dai Y, et al. Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway. Biosci Rep. 2018;38: pubmed 出版商
  152. Wang J, Wang F, Zhu J, Song M, An J, Li W. Transcriptome Profiling Reveals PHLDA1 as a Novel Molecular Marker for Ischemic Cardiomyopathy. J Mol Neurosci. 2018;65:102-109 pubmed 出版商
  153. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed 出版商
  154. Yang R, Tao Z, Huang M, Zheng Y, Dai M, Zou Y, et al. Knockout of the placenta specific 8 gene radiosensitizes nasopharyngeal carcinoma cells by activating the PI3K/AKT/GSK3β pathway. Am J Transl Res. 2018;10:455-464 pubmed
  155. Zhang S, Zhang M, Jing Y, Yin X, Ma P, Zhang Z, et al. Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors. Nat Commun. 2018;9:215 pubmed 出版商
  156. Kim M, Morales L, Baek M, Slaga T, DiGiovanni J, Kim D. UVB-induced nuclear translocation of TC-PTP by AKT/14-3-3? axis inhibits keratinocyte survival and proliferation. Oncotarget. 2017;8:90674-90692 pubmed 出版商
  157. Mai W, Gosa L, Daniëls V, Ta L, Tsang J, Higgins B, et al. Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma. Nat Med. 2017;23:1342-1351 pubmed 出版商
  158. Xie Z, Enkhjargal B, Wu L, Zhou K, Sun C, Hu X, et al. Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats. Neuropharmacology. 2018;128:142-151 pubmed 出版商
  159. Moncsek A, Al Suraih M, Trussoni C, O Hara S, Splinter P, Zuber C, et al. Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2-/- ) mice. Hepatology. 2017;: pubmed 出版商
  160. Zhang Y, Chen P, Hong H, Wang L, Zhou Y, Lang Y. JNK pathway mediates curcumin-induced apoptosis and autophagy in osteosarcoma MG63 cells. Exp Ther Med. 2017;14:593-599 pubmed 出版商
  161. Zhang K, Myllymäki S, Gao P, Devarajan R, Kytölä V, Nykter M, et al. Oncogenic K-Ras upregulates ITGA6 expression via FOSL1 to induce anoikis resistance and synergizes with αV-Class integrins to promote EMT. Oncogene. 2017;36:5681-5694 pubmed 出版商
  162. Zhang F, Zhu J, Li J, Zhu F, Zhang P. IRF2-INPP4B axis participates in the development of acute myeloid leukemia by regulating cell growth and survival. Gene. 2017;627:9-14 pubmed 出版商
  163. Angori S, Capanni C, Faulkner G, Bean C, Boriani G, Lattanzi G, et al. Emery-Dreifuss Muscular Dystrophy-Associated Mutant Forms of Lamin A Recruit the Stress Responsive Protein Ankrd2 into the Nucleus, Affecting the Cellular Response to Oxidative Stress. Cell Physiol Biochem. 2017;42:169-184 pubmed 出版商
  164. Liu Y, Chen X, Li J. Resveratrol protects against oxidized low‑density lipoprotein‑induced human umbilical vein endothelial cell apoptosis via inhibition of mitochondrial‑derived oxidative stress. Mol Med Rep. 2017;15:2457-2464 pubmed 出版商
  165. Lian W, Zhang L, Yang L, Chen W. AP-2α reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway. Apoptosis. 2017;22:933-941 pubmed 出版商
  166. Yang X, Zhao Q, Yin H, Lei X, Gan R. MiR-33b-5p sensitizes gastric cancer cells to chemotherapy drugs via inhibiting HMGA2 expression. J Drug Target. 2017;25:653-660 pubmed 出版商
  167. Hou J, Xue J, Lee M, Sung C. Ginsenoside Rd as a potential neuroprotective agent prevents trimethyltin injury. Biomed Rep. 2017;6:435-440 pubmed 出版商
  168. Gao Y, Zhuang Z, Gao S, Li X, Zhang Z, Ye Z, et al. Tetrahydrocurcumin reduces oxidative stress-induced apoptosis via the mitochondrial apoptotic pathway by modulating autophagy in rats after traumatic brain injury. Am J Transl Res. 2017;9:887-899 pubmed
  169. Jelinek M, Kabelova A, Srámek J, Seitz J, Ojima I, Kovar J. Differing Mechanisms of Death Induction by Fluorinated Taxane SB-T-12854 in Breast Cancer Cells. Anticancer Res. 2017;37:1581-1590 pubmed
  170. Paterniti I, Campolo M, Siracusa R, Cordaro M, Di Paola R, Calabrese V, et al. Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson's disease. PLoS ONE. 2017;12:e0174470 pubmed 出版商
  171. Yokoyama T, Kohn E, Brill E, Lee J. Apoptosis is augmented in high-grade serous ovarian cancer by the combined inhibition of Bcl-2/Bcl-xL and PARP. Int J Oncol. 2017;: pubmed 出版商
  172. Panigrahi S, Manterola M, Wolgemuth D. Meiotic failure in cyclin A1-deficient mouse spermatocytes triggers apoptosis through intrinsic and extrinsic signaling pathways and 14-3-3 proteins. PLoS ONE. 2017;12:e0173926 pubmed 出版商
  173. Sahu U, Choudhury A, Parvez S, Biswas S, Kar S. Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli. Cell Death Dis. 2017;8:e2667 pubmed 出版商
  174. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed 出版商
  175. Hong Y, Hong Y, Choi Y, Yeo S, Jin S, Lee S, et al. The Short Isoform of DNAJB6 Protects against 1-Methyl-4-phenylpridinium Ion-Induced Apoptosis in LN18 Cells via Inhibiting Both ROS Formation and Mitochondrial Membrane Potential Loss. Oxid Med Cell Longev. 2017;2017:7982389 pubmed 出版商
  176. Tian Y, Wu X, Guo S, Ma L, Huang W, Zhao X. Minocycline attenuates sevoflurane-induced cell injury via activation of Nrf2. Int J Mol Med. 2017;39:869-878 pubmed 出版商
  177. Fu S, Xu H, Gu M, Liu C, Wang Q, Wan X, et al. Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity. Sci Rep. 2017;7:43771 pubmed 出版商
  178. Shi J, Bei Y, Kong X, Liu X, Lei Z, Xu T, et al. miR-17-3p Contributes to Exercise-Induced Cardiac Growth and Protects against Myocardial Ischemia-Reperfusion Injury. Theranostics. 2017;7:664-676 pubmed 出版商
  179. Iurlaro R, Püschel F, León Annicchiarico C, O Connor H, Martin S, Palou Gramón D, et al. Glucose Deprivation Induces ATF4-Mediated Apoptosis through TRAIL Death Receptors. Mol Cell Biol. 2017;37: pubmed 出版商
  180. Dong Q, Li J, Wu Q, Zhao N, Qian C, Ding D, et al. Blockage of transient receptor potential vanilloid 4 alleviates myocardial ischemia/reperfusion injury in mice. Sci Rep. 2017;7:42678 pubmed 出版商
  181. Wu Q, Yan H, Tao S, Wang X, Mou L, Chen P, et al. XIAP 3'-untranslated region as a ceRNA promotes FSCN1 function in inducing the progression of breast cancer by binding endogenous miR-29a-5p. Oncotarget. 2017;8:16784-16800 pubmed 出版商
  182. Yuan H, Tan B, Gao S. Tenovin-6 impairs autophagy by inhibiting autophagic flux. Cell Death Dis. 2017;8:e2608 pubmed 出版商
  183. Abbaspour Babaei M, Zaman Huri H, Kamalidehghan B, Yeap S, Ahmadipour F. Apoptotic induction and inhibition of NF-?B signaling pathway in human prostatic cancer PC3 cells by natural compound 2,2'-oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea costalis: an in vitro study. Onco Targets Ther. 2017;10:277-294 pubmed 出版商
  184. Cayrol F, Praditsuktavorn P, Fernando T, Kwiatkowski N, Marullo R, Calvo Vidal M, et al. THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors. Nat Commun. 2017;8:14290 pubmed 出版商
  185. Ha S, Jin F, Kwak C, Abekura F, Park J, Park N, et al. Jellyfish extract induces apoptotic cell death through the p38 pathway and cell cycle arrest in chronic myelogenous leukemia K562 cells. Peerj. 2017;5:e2895 pubmed 出版商
  186. Li M, Yuan Y, Hu B, Wu L. Study on Lentivirus-Mediated ABCA7 Improves Neurocognitive Function and Related Mechanisms in the C57BL/6 Mouse Model of Alzheimer's Disease. J Mol Neurosci. 2017;61:489-497 pubmed 出版商
  187. Choi I, Hwang L, Jin J, Ko I, Kim S, Shin M, et al. Dexmedetomidine alleviates cerebral ischemia-induced short-term memory impairment by inhibiting the expression of apoptosis-related molecules in the hippocampus of gerbils. Exp Ther Med. 2017;13:107-116 pubmed 出版商
  188. Villar V, Nguyen T, Delcroix V, Terés S, Bouchecareilh M, Salin B, et al. mTORC1 inhibition in cancer cells protects from glutaminolysis-mediated apoptosis during nutrient limitation. Nat Commun. 2017;8:14124 pubmed 出版商
  189. Liu G, Xiang T, Wu Q, Wang W. Curcumin suppresses the proliferation of gastric cancer cells by downregulating H19. Oncol Lett. 2016;12:5156-5162 pubmed 出版商
  190. Peng Y, Shi X, Li Z, He X, Sun Y. Particularly interesting Cys-His-rich protein is highly expressed in human intracranial aneurysms and resists aneurysmal rupture. Exp Ther Med. 2016;12:3905-3912 pubmed 出版商
  191. Cao H, Yu S, Chen D, Jing C, Wang Z, Ma R, et al. Liver X receptor agonist T0901317 reverses resistance of A549 human lung cancer cells to EGFR-TKI treatment. FEBS Open Bio. 2017;7:35-43 pubmed 出版商
  192. Alcoba D, Schneider J, Arruda L, Martiny P, Capp E, von Eye Corleta H, et al. Brilliant cresyl blue staining does not present cytotoxic effects on human luteinized follicular cells, according to gene/protein expression, as well as to cytotoxicity tests. Reprod Biol. 2017;17:60-68 pubmed 出版商
  193. Brasacchio D, Alsop A, Noori T, Lufti M, Iyer S, Simpson K, et al. Epigenetic control of mitochondrial cell death through PACS1-mediated regulation of BAX/BAK oligomerization. Cell Death Differ. 2017;24:961-970 pubmed 出版商
  194. Hu N, Chang H, Du B, Zhang Q, Arfat Y, Dang K, et al. Tetramethylpyrazine ameliorated disuse-induced gastrocnemius muscle atrophy in hindlimb unloading rats through suppression of Ca2+/ROS-mediated apoptosis. Appl Physiol Nutr Metab. 2017;42:117-127 pubmed 出版商
  195. Grossi M, Bhattachariya A, Nordström I, Turczynska K, Svensson D, Albinsson S, et al. Pyk2 inhibition promotes contractile differentiation in arterial smooth muscle. J Cell Physiol. 2017;232:3088-3102 pubmed 出版商
  196. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed 出版商
  197. Chao M, Guo J, Cheng W, Zhu X, She Z, Huang Z, et al. Loss of Caspase-Activated DNase Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice. J Am Heart Assoc. 2016;5: pubmed 出版商
  198. Xiao F, Zhang J, Zhang C, An W. Hepatic stimulator substance inhibits calcium overflow through the mitochondria-associated membrane compartment during nonalcoholic steatohepatitis. Lab Invest. 2017;97:289-301 pubmed 出版商
  199. Tang Z, Li J, Shen Q, Feng J, Liu H, Wang W, et al. Contribution of upregulated dipeptidyl peptidase 9 (DPP9) in promoting tumoregenicity, metastasis and the prediction of poor prognosis in non-small cell lung cancer (NSCLC). Int J Cancer. 2017;140:1620-1632 pubmed 出版商
  200. Suzuki J, Nakajima W, Suzuki H, Asano Y, Tanaka N. Chaperone-mediated autophagy promotes lung cancer cell survival through selective stabilization of the pro-survival protein, MCL1. Biochem Biophys Res Commun. 2017;482:1334-1340 pubmed 出版商
  201. Park S, Jwa E, Shin S, Ju E, Park I, Pak J, et al. Ibulocydine sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis via calpain-mediated Bax cleavage. Int J Biochem Cell Biol. 2017;83:47-55 pubmed 出版商
  202. He X, Liu Z, Xia Y, Xu J, Lv G, Wang L, et al. HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs. Oncotarget. 2017;8:1247-1261 pubmed 出版商
  203. Zhao J, Sang M, Geng C, Wang S, Shan B. A novel curcumin analogue is a potent chemotherapy candidate for human hepatocellular carcinoma. Oncol Lett. 2016;12:4252-4262 pubmed
  204. Liu Z, Gan L, Wu T, Feng F, Luo D, Gu H, et al. Adiponectin reduces ER stress-induced apoptosis through PPARα transcriptional regulation of ATF2 in mouse adipose. Cell Death Dis. 2016;7:e2487 pubmed 出版商
  205. Zhu X, Wang K, Zhang K, Zhang T, Yin Y, Xu F. Ziyuglycoside I Inhibits the Proliferation of MDA-MB-231 Breast Carcinoma Cells through Inducing p53-Mediated G2/M Cell Cycle Arrest and Intrinsic/Extrinsic Apoptosis. Int J Mol Sci. 2016;17: pubmed
  206. Yang S, Lee D, Shin J, Lee S, Baek S, Kim J, et al. Nec-1 alleviates cognitive impairment with reduction of Aβ and tau abnormalities in APP/PS1 mice. EMBO Mol Med. 2017;9:61-77 pubmed 出版商
  207. Shi D, Liu Y, Xi R, Zou W, Wu L, Zhang Z, et al. Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells. Int J Nanomedicine. 2016;11:5823-5835 pubmed
  208. Singh A, Agrahari A, Singh R, Yadav S, Srivastava V, Parmar D. Imprinting of cerebral cytochrome P450s in offsprings prenatally exposed to cypermethrin augments toxicity on rechallenge. Sci Rep. 2016;6:37426 pubmed 出版商
  209. Martínez Castillo M, Bonilla Moreno R, Alemán Lazarini L, Meraz Rios M, Orozco L, Cedillo Barron L, et al. A Subpopulation of the K562 Cells Are Killed by Curcumin Treatment after G2/M Arrest and Mitotic Catastrophe. PLoS ONE. 2016;11:e0165971 pubmed 出版商
  210. Pan S, Li S, Hu Y, Zhang H, Liu Y, Jiang H, et al. Resveratrol post-treatment protects against neonatal brain injury after hypoxia-ischemia. Oncotarget. 2016;7:79247-79261 pubmed 出版商
  211. Lee J, Westrate L, Wu H, Page C, Voeltz G. Multiple dynamin family members collaborate to drive mitochondrial division. Nature. 2016;540:139-143 pubmed 出版商
  212. Tu S, Lin Y, Huang C, Yang P, Chang H, Chang C, et al. Protein phosphatase Mg2+/Mn2+ dependent 1F promotes smoking-induced breast cancer by inactivating phosphorylated-p53-induced signals. Oncotarget. 2016;7:77516-77531 pubmed 出版商
  213. Dey K, Bharti R, Dey G, Pal I, Rajesh Y, Chavan S, et al. S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway. Cancer Gene Ther. 2016;23:382-391 pubmed 出版商
  214. Ulbrich F, Kaufmann K, Meske A, Lagrèze W, Augustynik M, Buerkle H, et al. The CORM ALF-186 Mediates Anti-Apoptotic Signaling via an Activation of the p38 MAPK after Ischemia and Reperfusion Injury in Retinal Ganglion Cells. PLoS ONE. 2016;11:e0165182 pubmed 出版商
  215. Matsuura K, Huang N, Cocce K, Zhang L, Kornbluth S. Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin. Oncogene. 2017;36:1698-1706 pubmed 出版商
  216. Zhan Y, Mou L, Cheng K, Wang C, Deng X, Chen J, et al. Hepatocellular carcinoma stem cell-like cells are enriched following low-dose 5-fluorouracil chemotherapy. Oncol Lett. 2016;12:2511-2516 pubmed
  217. Wang C, Zhang F, Cao Y, Zhang M, Wang A, Xu M, et al. Etoposide Induces Apoptosis in Activated Human Hepatic Stellate Cells via ER Stress. Sci Rep. 2016;6:34330 pubmed 出版商
  218. Wei R, Lin S, Wu W, Chen L, Li C, Chen H, et al. A microtubule inhibitor, ABT-751, induces autophagy and delays apoptosis in Huh-7 cells. Toxicol Appl Pharmacol. 2016;311:88-98 pubmed 出版商
  219. Cao R, Meng Z, Liu T, Wang G, Qian G, Cao T, et al. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway. Oncotarget. 2016;7:72941-72960 pubmed 出版商
  220. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed 出版商
  221. Bahr J, Robey R, Luchenko V, Basseville A, Chakraborty A, Kozlowski H, et al. Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras. Oncotarget. 2016;7:69804-69815 pubmed 出版商
  222. Klingbeil O, Lesche R, Gelato K, Haendler B, Lejeune P. Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agents. Cell Death Dis. 2016;7:e2365 pubmed 出版商
  223. Heulot M, Chevalier N, Puyal J, Margue C, Michel S, Kreis S, et al. The TAT-RasGAP317-326 anti-cancer peptide can kill in a caspase-, apoptosis-, and necroptosis-independent manner. Oncotarget. 2016;7:64342-64359 pubmed 出版商
  224. Park S, Jo D, Jo S, Shin D, Shim S, Jo Y, et al. Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death. Oncotarget. 2016;7:65957-65967 pubmed 出版商
  225. Suman S, Kumar S, N GOUEMO P, Datta K. Increased DNA double-strand break was associated with downregulation of repair and upregulation of apoptotic factors in rat hippocampus after alcohol exposure. Alcohol. 2016;54:45-50 pubmed 出版商
  226. Cheng S, Jiang X, Ding C, Du C, Owusu Ansah K, Weng X, et al. Expression and Critical Role of Interleukin Enhancer Binding Factor 2 in Hepatocellular Carcinoma. Int J Mol Sci. 2016;17: pubmed 出版商
  227. Li H, Yang X, Wang G, Li X, Tao D, Hu J, et al. KDM4B plays an important role in mitochondrial apoptosis by upregulating HAX1 expression in colorectal cancer. Oncotarget. 2016;7:57866-57877 pubmed 出版商
  228. Liu Y, Wang Y, Ding G, Yang T, Yao L, Hua J, et al. JAK2 inhibitor combined with DC-activated AFP-specific T-cells enhances antitumor function in a Fas/FasL signal-independent pathway. Onco Targets Ther. 2016;9:4425-33 pubmed 出版商
  229. Riascos Bernal D, Chinnasamy P, Cao L, Dunaway C, Valenta T, Basler K, et al. β-Catenin C-terminal signals suppress p53 and are essential for artery formation. Nat Commun. 2016;7:12389 pubmed 出版商
  230. Shi Y, He Z, Jia Z, Xu C. Inhibitory effect of metformin combined with gemcitabine on pancreatic cancer cells in vitro and in vivo. Mol Med Rep. 2016;14:2921-8 pubmed 出版商
  231. Martinez L, Thames E, Kim J, Chaudhuri G, Singh R, Pervin S. Increased sensitivity of African American triple negative breast cancer cells to nitric oxide-induced mitochondria-mediated apoptosis. BMC Cancer. 2016;16:559 pubmed 出版商
  232. Liu H, Li W, Yu X, Gao F, Duan Z, Ma X, et al. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis. Oncotarget. 2016;7:56338-56354 pubmed 出版商
  233. Bao H, Liu P, Jiang K, Zhang X, Xie L, Wang Z, et al. Huaier polysaccharide induces apoptosis in hepatocellular carcinoma cells through p38 MAPK. Oncol Lett. 2016;12:1058-1066 pubmed
  234. Yu X, Sun K, Tang X, Zhou C, Sun H, Yan Z, et al. Harmine combined with paclitaxel inhibits tumor proliferation and induces apoptosis through down-regulation of cyclooxygenase-2 expression in gastric cancer. Oncol Lett. 2016;12:983-988 pubmed
  235. Ma T, Fan B, Zhang C, Zhao H, Han C, Gao C, et al. Metabonomics applied in exploring the antitumour mechanism of physapubenolide on hepatocellular carcinoma cells by targeting glycolysis through the Akt-p53 pathway. Sci Rep. 2016;6:29926 pubmed 出版商
  236. Ahmed N, Murakami M, Hirose Y, Nakashima M. Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer's Disease Treatment: An In Vitro Study. Stem Cells Int. 2016;2016:8102478 pubmed 出版商
  237. Rohlenova K, Sachaphibulkij K, Stursa J, Bezawork Geleta A, Blecha J, Endaya B, et al. Selective Disruption of Respiratory Supercomplexes as a New Strategy to Suppress Her2high Breast Cancer. Antioxid Redox Signal. 2017;26:84-103 pubmed 出版商
  238. Qi L, Lv X, Zhang T, Jia P, Yan R, Li S, et al. Cytotoxicity and genotoxicity of bacterial magnetosomes against human retinal pigment epithelium cells. Sci Rep. 2016;6:26961 pubmed 出版商
  239. Amara S, Zheng M, Tiriveedhi V. Oleanolic Acid Inhibits High Salt-Induced Exaggeration of Warburg-like Metabolism in Breast Cancer Cells. Cell Biochem Biophys. 2016;74:427-34 pubmed 出版商
  240. Megyesi J, Tarcsafalvi A, Seng N, Hodeify R, Price P. Cdk2 phosphorylation of Bcl-xL after stress converts it to a pro-apoptotic protein mimicking Bax/Bak. Cell Death Discov. 2016;2: pubmed
  241. Wang J, Hu K, Guo J, Cheng F, Lv J, Jiang W, et al. Suppression of KRas-mutant cancer through the combined inhibition of KRAS with PLK1 and ROCK. Nat Commun. 2016;7:11363 pubmed 出版商
  242. Liu B, Shi Y, Peng W, Zhang Q, Liu J, Chen N, et al. Diosmetin induces apoptosis by upregulating p53 via the TGF-? signal pathway in HepG2 hepatoma cells. Mol Med Rep. 2016;14:159-64 pubmed 出版商
  243. Gao Z, Liu Z, Bi M, Zhang J, Han Z, Han X, et al. Metformin induces apoptosis via a mitochondria-mediated pathway in human breast cancer cells in vitro. Exp Ther Med. 2016;11:1700-1706 pubmed
  244. Keilhoff G, Lucas B, Uhde K, Fansa H. Selected gene profiles of stressed NSC-34 cells and rat spinal cord following peripheral nerve reconstruction and minocycline treatment. Exp Ther Med. 2016;11:1685-1699 pubmed
  245. Nakajima W, Sharma K, Lee J, Maxim N, Hicks M, Vu T, et al. DNA damaging agent-induced apoptosis is regulated by MCL-1 phosphorylation and degradation mediated by the Noxa/MCL-1/CDK2 complex. Oncotarget. 2016;7:36353-36365 pubmed 出版商
  246. Zhao J, Niu X, Li X, Edwards H, Wang G, Wang Y, et al. Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells. Oncotarget. 2016;7:34785-99 pubmed 出版商
  247. Wang W, Zhan M, Li Q, Chen W, Chu H, Huang Q, et al. FXR agonists enhance the sensitivity of biliary tract cancer cells to cisplatin via SHP dependent inhibition of Bcl-xL expression. Oncotarget. 2016;7:34617-29 pubmed 出版商
  248. Yao J, Wang Y, Fang B, Zhang S, Cheng B. piR-651 and its function in 95-D lung cancer cells. Biomed Rep. 2016;4:546-550 pubmed
  249. Kim H, Oh J, Choi S, Nam Y, Jo A, Kwon A, et al. Down-regulation of p21-activated serine/threonine kinase 1 is involved in loss of mesencephalic dopamine neurons. Mol Brain. 2016;9:45 pubmed 出版商
  250. Swiader A, Nahapetyan H, Faccini J, D Angelo R, Mucher E, Elbaz M, et al. Mitophagy acts as a safeguard mechanism against human vascular smooth muscle cell apoptosis induced by atherogenic lipids. Oncotarget. 2016;7:28821-35 pubmed 出版商
  251. Song J, Wang Y, Teng M, Zhang S, Yin M, Lu J, et al. Cordyceps militaris induces tumor cell death via the caspase?dependent mitochondrial pathway in HepG2 and MCF?7 cells. Mol Med Rep. 2016;13:5132-40 pubmed 出版商
  252. Pallis M, Burrows F, Ryan J, Grundy M, Seedhouse C, Abdul Aziz A, et al. Complementary dynamic BH3 profiles predict co-operativity between the multi-kinase inhibitor TG02 and the BH3 mimetic ABT-199 in acute myeloid leukaemia cells. Oncotarget. 2017;8:16220-16232 pubmed 出版商
  253. Pires A, Marques C, Encarnação J, Abrantes A, Mamede A, Laranjo M, et al. Ascorbic acid and colon cancer: an oxidative stimulus to cell death depending on cell profile. Eur J Cell Biol. 2016;95:208-18 pubmed 出版商
  254. Jeong J, Noh M, Choi J, Lee H, Kim S. Neuroprotective and antioxidant activities of bamboo salt soy sauce against H2O2-induced oxidative stress in rat cortical neurons. Exp Ther Med. 2016;11:1201-1210 pubmed
  255. Wang H, Zhang H, Chen X, Zhao T, Kong Q, Yan M, et al. The decreased expression of electron transfer flavoprotein ? is associated with tubular cell apoptosis in diabetic nephropathy. Int J Mol Med. 2016;37:1290-8 pubmed 出版商
  256. Strickland S, Vande Pol S. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC. J Virol. 2016;90:5611-5621 pubmed 出版商
  257. Huang J, Yao C, Chuang S, Yeh C, Lee L, Chen R, et al. Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction. BMC Cancer. 2016;16:245 pubmed 出版商
  258. Du K, Farhood A, Jaeschke H. Mitochondria-targeted antioxidant Mito-Tempo protects against acetaminophen hepatotoxicity. Arch Toxicol. 2017;91:761-773 pubmed 出版商
  259. Li B, Chen D, Li W, Xiao D. 20(S)-Protopanaxadiol saponins inhibit SKOV3 cell migration. Oncol Lett. 2016;11:1693-1698 pubmed
  260. Matsumoto M, Nakajima W, Seike M, Gemma A, Tanaka N. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells. Biochem Biophys Res Commun. 2016;473:490-6 pubmed 出版商
  261. Tervaniemi M, Katayama S, Skoog T, Siitonen H, Vuola J, Nuutila K, et al. NOD-like receptor signaling and inflammasome-related pathways are highlighted in psoriatic epidermis. Sci Rep. 2016;6:22745 pubmed 出版商
  262. Li J, Su Y, Wang H, Zhao Y, Liao X, Wang X, et al. Repeated Blockade of NMDA Receptors During Adolescence Impairs Reversal Learning and Disrupts GABAergic Interneurons in Rat Medial Prefrontal Cortex. Front Mol Neurosci. 2016;9:17 pubmed 出版商
  263. Brito A, Ribeiro M, Abrantes A, Mamede A, Laranjo M, Casalta Lopes J, et al. New Approach for Treatment of Primary Liver Tumors: The Role of Quercetin. Nutr Cancer. 2016;68:250-66 pubmed 出版商
  264. Nakayama R, Zhang Y, Czaplinski J, Anatone A, Sicinska E, Fletcher J, et al. Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma. Oncotarget. 2016;7:16581-92 pubmed 出版商
  265. Yu L, Wu W, Gu C, Zhong D, Zhao X, Kong Y, et al. Obatoclax impairs lysosomal function to block autophagy in cisplatin-sensitive and -resistant esophageal cancer cells. Oncotarget. 2016;7:14693-707 pubmed 出版商
  266. Urnukhsaikhan E, Cho H, Mishig Ochir T, Seo Y, Park J. Pulsed electromagnetic fields promote survival and neuronal differentiation of human BM-MSCs. Life Sci. 2016;151:130-138 pubmed 出版商
  267. Yang C, Cui X, Dai X, Liao W. Downregulation of Foxc2 enhances apoptosis induced by 5-fluorouracil through activation of MAPK and AKT pathways in colorectal cancer. Oncol Lett. 2016;11:1549-1554 pubmed
  268. Kline C, van den Heuvel A, Allen J, Prabhu V, Dicker D, El Deiry W. ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases. Sci Signal. 2016;9:ra18 pubmed 出版商
  269. Zhao X, Song X, Bai X, Fei N, Huang Y, Zhao Z, et al. miR-27b attenuates apoptosis induced by transmissible gastroenteritis virus (TGEV) infection via targeting runt-related transcription factor 1 (RUNX1). Peerj. 2016;4:e1635 pubmed 出版商
  270. Preet R, Siddharth S, Satapathy S, Das S, Nayak A, Das D, et al. Chk1 inhibitor synergizes quinacrine mediated apoptosis in breast cancer cells by compromising the base excision repair cascade. Biochem Pharmacol. 2016;105:23-33 pubmed 出版商
  271. Zhang Y, Zou C, Yang S, Fu J. P120 catenin attenuates the angiotensin II-induced apoptosis of human umbilical vein endothelial cells by suppressing the mitochondrial pathway. Int J Mol Med. 2016;37:623-30 pubmed 出版商
  272. Chen B, Song G, Liu M, Qian L, Wang L, Gu H, et al. Inhibition of miR-29c promotes proliferation, and inhibits apoptosis and differentiation in P19 embryonic carcinoma cells. Mol Med Rep. 2016;13:2527-35 pubmed 出版商
  273. Li Y, Liu J, Gao D, Wei J, Yuan H, Niu X, et al. Age-related changes in hypertensive brain damage in the hippocampi of spontaneously hypertensive rats. Mol Med Rep. 2016;13:2552-60 pubmed 出版商
  274. Le Pen J, Maillet L, Sarosiek K, Vuillier C, Gautier F, Montessuit S, et al. Constitutive p53 heightens mitochondrial apoptotic priming and favors cell death induction by BH3 mimetic inhibitors of BCL-xL. Cell Death Dis. 2016;7:e2083 pubmed 出版商
  275. Esfandiari A, Hawthorne T, Nakjang S, Lunec J. Chemical Inhibition of Wild-Type p53-Induced Phosphatase 1 (WIP1/PPM1D) by GSK2830371 Potentiates the Sensitivity to MDM2 Inhibitors in a p53-Dependent Manner. Mol Cancer Ther. 2016;15:379-91 pubmed 出版商
  276. Xue T, Tao L, Zhang J, Zhang P, Liu X, Chen G, et al. Intestinal ischemic preconditioning reduces liver ischemia reperfusion injury in rats. Mol Med Rep. 2016;13:2511-7 pubmed 出版商
  277. Raemy E, Montessuit S, Pierredon S, van Kampen A, Vaz F, Martinou J. Cardiolipin or MTCH2 can serve as tBID receptors during apoptosis. Cell Death Differ. 2016;23:1165-74 pubmed 出版商
  278. Kato R, Hasegawa K, Torii Y, Udagawa Y, Fukasawa I. Factors affecting platinum sensitivity in cervical cancer. Oncol Lett. 2015;10:3591-3598 pubmed
  279. Choi S, Chen Z, Tang L, Fang Y, Shin S, Panarelli N, et al. Bcl-xL promotes metastasis independent of its anti-apoptotic activity. Nat Commun. 2016;7:10384 pubmed 出版商
  280. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed 出版商
  281. Wu M, Ai W, Chen L, Zhao S, Liu E. Bradykinin receptors and EphB2/EphrinB2 pathway in response to high glucose-induced osteoblast dysfunction and hyperglycemia-induced bone deterioration in mice. Int J Mol Med. 2016;37:565-74 pubmed 出版商
  282. Soragni A, Janzen D, Johnson L, Lindgren A, Thai Quynh Nguyen A, Tiourin E, et al. A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas. Cancer Cell. 2016;29:90-103 pubmed 出版商
  283. Zhang H, Xiong Z, Wang J, Zhang S, Lei L, Yang L, et al. Glucagon-like peptide-1 protects cardiomyocytes from advanced oxidation protein product-induced apoptosis via the PI3K/Akt/Bad signaling pathway. Mol Med Rep. 2016;13:1593-601 pubmed 出版商
  284. Wang F, Feng Y, Li P, Wang K, Feng L, Liu Y, et al. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma. Oncotarget. 2016;7:4279-97 pubmed 出版商
  285. Bishayee A, Mandal A, Bhattacharyya P, Bhatia D. Pomegranate exerts chemoprevention of experimentally induced mammary tumorigenesis by suppression of cell proliferation and induction of apoptosis. Nutr Cancer. 2016;68:120-30 pubmed 出版商
  286. Nakajima W, Sharma K, Hicks M, Le N, Brown R, Krystal G, et al. Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer. Cancer Biol Ther. 2016;17:27-35 pubmed 出版商
  287. Wang S, Song T, Leng C, Lan K, Ning J, Chu H. Propofol protects against the neurotoxicity of 1‑methyl‑4‑phenylpyridinium. Mol Med Rep. 2016;13:309-14 pubmed 出版商
  288. Stanojlović M, GuÅ¡evac I, Grković I, Zlatković J, Mitrović N, Zarić M, et al. Effects of chronic cerebral hypoperfusion and low-dose progesterone treatment on apoptotic processes, expression and subcellular localization of key elements within Akt and Erk signaling pathways in rat hippocampus. Neuroscience. 2015;311:308-21 pubmed 出版商
  289. Nichols C, Shepherd D, Knuckles T, Thapa D, Stricker J, Stapleton P, et al. Cardiac and mitochondrial dysfunction following acute pulmonary exposure to mountaintop removal mining particulate matter. Am J Physiol Heart Circ Physiol. 2015;309:H2017-30 pubmed 出版商
  290. Gu Y, Zhang Y, Bi Y, Liu J, Tan B, Gong M, et al. Mesenchymal stem cells suppress neuronal apoptosis and decrease IL-10 release via the TLR2/NFκB pathway in rats with hypoxic-ischemic brain damage. Mol Brain. 2015;8:65 pubmed 出版商
  291. Campo Verde Arboccó F, Sasso C, Actis E, Carón R, Hapon M, Jahn G. Hypothyroidism advances mammary involution in lactating rats through inhibition of PRL signaling and induction of LIF/STAT3 mRNAs. Mol Cell Endocrinol. 2016;419:18-28 pubmed 出版商
  292. Jiang Y, Du M, Wu M, Zhu Y, Zhao X, Cao X, et al. Phosphatidic Acid Improves Reprogramming to Pluripotency by Reducing Apoptosis. Stem Cells Dev. 2016;25:43-54 pubmed 出版商
  293. Xu Z, Chen X, Jin X, Meng X, Zhou X, Fan F, et al. SILAC-based proteomic analysis reveals that salidroside antagonizes cobalt chloride-induced hypoxic effects by restoring the tricarboxylic acid cycle in cardiomyocytes. J Proteomics. 2016;130:211-20 pubmed 出版商
  294. Kramer H, Lai C, Patel H, Periyasamy M, Lin M, Feller S, et al. LRH-1 drives colon cancer cell growth by repressing the expression of the CDKN1A gene in a p53-dependent manner. Nucleic Acids Res. 2016;44:582-94 pubmed 出版商
  295. Singh S, Chand H, Gundavarapu S, Saeed A, Langley R, Tesfaigzi Y, et al. HIF-1α Plays a Critical Role in the Gestational Sidestream Smoke-Induced Bronchopulmonary Dysplasia in Mice. PLoS ONE. 2015;10:e0137757 pubmed 出版商
  296. Ray A, Vasudevan S, Sengupta S. 6-Shogaol Inhibits Breast Cancer Cells and Stem Cell-Like Spheroids by Modulation of Notch Signaling Pathway and Induction of Autophagic Cell Death. PLoS ONE. 2015;10:e0137614 pubmed 出版商
  297. Yao K, Wu J, Zhang J, Bo J, Hong Z, Zu H. Protective Effect of DHT on Apoptosis Induced by U18666A via PI3K/Akt Signaling Pathway in C6 Glial Cell Lines. Cell Mol Neurobiol. 2016;36:801-9 pubmed 出版商
  298. Jung S, Li C, Duan J, Lee S, Kim K, Park Y, et al. TRIP-Br1 oncoprotein inhibits autophagy, apoptosis, and necroptosis under nutrient/serum-deprived condition. Oncotarget. 2015;6:29060-75 pubmed 出版商
  299. Lavik A, Zhong F, Chang M, Greenberg E, Choudhary Y, Smith M, et al. A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2. Oncotarget. 2015;6:27388-402 pubmed 出版商
  300. Zhao C, Su Y, Zhang J, Feng Q, Qu L, Wang L, et al. Fibrinogen-derived fibrinostatin inhibits tumor growth through anti-angiogenesis. Cancer Sci. 2015;106:1596-606 pubmed 出版商
  301. Lee S, Kim J, Hong S, Lee A, Park E, Seo H, et al. High Inorganic Phosphate Intake Promotes Tumorigenesis at Early Stages in a Mouse Model of Lung Cancer. PLoS ONE. 2015;10:e0135582 pubmed 出版商
  302. Zhang X, Wang X, Wu T, Li B, Liu T, Wang R, et al. Isoliensinine induces apoptosis in triple-negative human breast cancer cells through ROS generation and p38 MAPK/JNK activation. Sci Rep. 2015;5:12579 pubmed 出版商
  303. Zhang L, Dai F, Sheng P, Chen Z, Xu Q, Guo Y. Resveratrol analogue 3,4,4'-trihydroxy-trans-stilbene induces apoptosis and autophagy in human non-small-cell lung cancer cells in vitro. Acta Pharmacol Sin. 2015;36:1256-65 pubmed 出版商
  304. Shi L, Teng H, Zhu M, Li C, Huang K, Chen B, et al. Paeoniflorin inhibits nucleus pulposus cell apoptosis by regulating the expression of Bcl-2 family proteins and caspase-9 in a rabbit model of intervertebral disc degeneration. Exp Ther Med. 2015;10:257-262 pubmed
  305. Liu B, Huang W, Xiao X, Xu Y, Ma S, Xia Z. Neuroprotective Effect of Ulinastatin on Spinal Cord Ischemia-Reperfusion Injury in Rabbits. Oxid Med Cell Longev. 2015;2015:624819 pubmed 出版商
  306. Deben C, Wouters A, Op de Beeck K, Van den Bossche J, Jacobs J, Zwaenepoel K, et al. The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer. Oncotarget. 2015;6:22666-79 pubmed
  307. Romano S, Xiao Y, Nakaya M, D Angelillo A, Chang M, Jin J, et al. FKBP51 employs both scaffold and isomerase functions to promote NF-κB activation in melanoma. Nucleic Acids Res. 2015;43:6983-93 pubmed 出版商
  308. Balzamino B, Esposito G, Marino R, Keller F, Micera A. NGF Expression in Reelin-Deprived Retinal Cells: A Potential Neuroprotective Effect. Neuromolecular Med. 2015;17:314-25 pubmed 出版商
  309. Kotipatruni R, Ren X, Thotala D, Jaboin J. NDRG4 is a novel oncogenic protein and p53 associated regulator of apoptosis in malignant meningioma cells. Oncotarget. 2015;6:17594-604 pubmed
  310. Schuler F, Baumgartner F, Klepsch V, Chamson M, Müller Holzner E, Watson C, et al. The BH3-only protein BIM contributes to late-stage involution in the mouse mammary gland. Cell Death Differ. 2016;23:41-51 pubmed 出版商
  311. Huang C, Lee C, Lin H, Chen M, Lin C, Chang J. Autophagy-Regulated ROS from Xanthine Oxidase Acts as an Early Effector for Triggering Late Mitochondria-Dependent Apoptosis in Cathepsin S-Targeted Tumor Cells. PLoS ONE. 2015;10:e0128045 pubmed 出版商
  312. Matsumoto T, Urushido M, Ide H, Ishihara M, Hamada Ode K, Shimamura Y, et al. Small Heat Shock Protein Beta-1 (HSPB1) Is Upregulated and Regulates Autophagy and Apoptosis of Renal Tubular Cells in Acute Kidney Injury. PLoS ONE. 2015;10:e0126229 pubmed 出版商
  313. Zhang L, Wang H, Ding K, Xu J. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells. Toxicol Lett. 2015;236:43-59 pubmed 出版商
  314. Zou Z, Cai Y, Chen Y, Chen S, Liu L, Shen Z, et al. Bone marrow-derived mesenchymal stem cells attenuate acute liver injury and regulate the expression of fibrinogen-like-protein 1 and signal transducer and activator of transcription 3. Mol Med Rep. 2015;12:2089-97 pubmed 出版商
  315. Hotokezaka Y, Katayama I, van Leyen K, Nakamura T. GSK-3β-dependent downregulation of γ-taxilin and αNAC merge to regulate ER stress responses. Cell Death Dis. 2015;6:e1719 pubmed 出版商
  316. Grav L, Lee J, Gerling S, Kallehauge T, Hansen A, Kol S, et al. One-step generation of triple knockout CHO cell lines using CRISPR/Cas9 and fluorescent enrichment. Biotechnol J. 2015;10:1446-56 pubmed 出版商
  317. Wang Y, Lv J, Cheng Y, DU J, Chen D, Li C, et al. Apoptosis induced by Ginkgo biloba (EGb761) in melanoma cells is Mcl-1-dependent. PLoS ONE. 2015;10:e0124812 pubmed 出版商
  318. Freeman J, Feng Y, Demehri F, Dempsey P, Teitelbaum D. TPN-associated intestinal epithelial cell atrophy is modulated by TLR4/EGF signaling pathways. FASEB J. 2015;29:2943-58 pubmed 出版商
  319. Seo H, Woo J, Shin Y, Ko S. Identification of biomarkers regulated by rexinoids (LGD1069, LG100268 and Ro25-7386) in human breast cells using Affymetrix microarray. Mol Med Rep. 2015;12:800-18 pubmed 出版商
  320. Schüll S, Günther S, Brodesser S, Seeger J, Tosetti B, Wiegmann K, et al. Cytochrome c oxidase deficiency accelerates mitochondrial apoptosis by activating ceramide synthase 6. Cell Death Dis. 2015;6:e1691 pubmed 出版商
  321. Li B, Li H, Wang Z, Wang Y, Gao A, Cui Y, et al. Evidence for the role of phosphatidylcholine-specific phospholipase in experimental subarachnoid hemorrhage in rats. Exp Neurol. 2015;272:145-51 pubmed 出版商
  322. Wei Z, Yu D, Bi Y, Cao Y. A disintegrin and metalloprotease 17 promotes microglial cell survival via epidermal growth factor receptor signalling following spinal cord injury. Mol Med Rep. 2015;12:63-70 pubmed 出版商
  323. Vogel C, Smit M, Maddalo G, Possik P, Sparidans R, van der Burg S, et al. Cooperative induction of apoptosis in NRAS mutant melanoma by inhibition of MEK and ROCK. Pigment Cell Melanoma Res. 2015;28:307-17 pubmed 出版商
  324. Li C, Jung S, Lee S, Jeong D, Yang Y, Kim K, et al. Nutrient/serum starvation derived TRIP-Br3 down-regulation accelerates apoptosis by destabilizing XIAP. Oncotarget. 2015;6:7522-35 pubmed
  325. Zhong T, Xu F, Xu J, Liu L, Chen Y. Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN loss. Biomed Pharmacother. 2015;69:317-25 pubmed 出版商
  326. Suo H, Song J, Zhou Y, Liu Z, Yi R, Zhu K, et al. Induction of apoptosis in HCT-116 colon cancer cells by polysaccharide of Larimichthys crocea swim bladder. Oncol Lett. 2015;9:972-978 pubmed
  327. Han M, Woo S, Min K, Kim S, Park J, Kim D, et al. 6-Shogaol enhances renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated cytochrome c release and down-regulation of c-FLIP(L) expression. Chem Biol Interact. 2015;228:69-78 pubmed 出版商
  328. Wang S, Geng Z, Shi N, Li X, Wang Z. Dose-dependent effects of selenite (Se(4+)) on arsenite (As(3+))-induced apoptosis and differentiation in acute promyelocytic leukemia cells. Cell Death Dis. 2015;6:e1596 pubmed 出版商
  329. Gurzu S, Kádár Z, Sugimura H, Bara T, Hălmaciu I, Jung I. Gastric cancer in young vs old Romanian patients: immunoprofile with emphasis on maspin and mena protein reactivity. APMIS. 2015;123:223-33 pubmed 出版商
  330. Gao F, Chen S, Sun M, Mitchel R, Li B, Chu Z, et al. MiR-467a is upregulated in radiation-induced mouse thymic lymphomas and regulates apoptosis by targeting Fas and Bax. Int J Biol Sci. 2015;11:109-21 pubmed 出版商
  331. Bharti S, Rani N, Bhatia J, Arya D. 5-HT2B receptor blockade attenuates β-adrenergic receptor-stimulated myocardial remodeling in rats via inhibiting apoptosis: role of MAPKs and HSPs. Apoptosis. 2015;20:455-65 pubmed 出版商
  332. Machado Neto J, Lazarini M, Favaro P, de Melo Campos P, Scopim Ribeiro R, Franchi Junior G, et al. ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells. Biochim Biophys Acta. 2015;1853:583-93 pubmed 出版商
  333. Bernusso V, Machado Neto J, Pericole F, Vieira K, Duarte A, Traina F, et al. Imatinib restores VASP activity and its interaction with Zyxin in BCR-ABL leukemic cells. Biochim Biophys Acta. 2015;1853:388-95 pubmed 出版商
  334. Cho S, Cho M, Kim J, Kaeberlein M, Lee S, Suh Y. Syringaresinol protects against hypoxia/reoxygenation-induced cardiomyocytes injury and death by destabilization of HIF-1α in a FOXO3-dependent mechanism. Oncotarget. 2015;6:43-55 pubmed
  335. Wang T, Guo S, Liu Z, Wu L, Li M, Yang J, et al. CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling. Oncotarget. 2014;5:10293-306 pubmed
  336. Zheng R, Hu W, Sui C, Ma N, Jiang Y. Effects of doxorubicin and gemcitabine on the induction of apoptosis in breast cancer cells. Oncol Rep. 2014;32:2719-25 pubmed 出版商
  337. Patwardhan G, Hosain S, Liu D, Khiste S, Zhao Y, Bielawski J, et al. Ceramide modulates pre-mRNA splicing to restore the expression of wild-type tumor suppressor p53 in deletion-mutant cancer cells. Biochim Biophys Acta. 2014;1841:1571-80 pubmed 出版商
  338. Mohamed H, el Swefy S, Hasan R, HASAN A. Neuroprotective effect of resveratrol in diabetic cerebral ischemic-reperfused rats through regulation of inflammatory and apoptotic events. Diabetol Metab Syndr. 2014;6:88 pubmed 出版商
  339. Nicholson A, Guo X, Sullivan C, Cha C. Automated quantitative analysis of tissue microarray of 443 patients with colorectal adenocarcinoma: low expression of Bcl-2 predicts poor survival. J Am Coll Surg. 2014;219:977-87 pubmed 出版商
  340. Senturk S, Yao Z, Camiolo M, Stiles B, Rathod T, Walsh A, et al. p53? is a transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like state. Proc Natl Acad Sci U S A. 2014;111:E3287-96 pubmed 出版商
  341. Su C, Sun F, Cunningham R, Rybalchenko N, Singh M. ERK5/KLF4 signaling as a common mediator of the neuroprotective effects of both nerve growth factor and hydrogen peroxide preconditioning. Age (Dordr). 2014;36:9685 pubmed 出版商
  342. Charan R, Johnson B, Zaganelli S, Nardozzi J, LaVoie M. Inhibition of apoptotic Bax translocation to the mitochondria is a central function of parkin. Cell Death Dis. 2014;5:e1313 pubmed 出版商
  343. Liu X, Gu Q, Duan K, Li Z. NMDA receptor-dependent LTD is required for consolidation but not acquisition of fear memory. J Neurosci. 2014;34:8741-8 pubmed 出版商
  344. Bai L, Chen J, McEachern D, Liu L, Zhou H, Aguilar A, et al. BM-1197: a novel and specific Bcl-2/Bcl-xL inhibitor inducing complete and long-lasting tumor regression in vivo. PLoS ONE. 2014;9:e99404 pubmed 出版商
  345. Neher M, Rich M, Keene C, Weckbach S, Bolden A, Losacco J, et al. Deficiency of complement receptors CR2/CR1 in Cr2?/? mice reduces the extent of secondary brain damage after closed head injury. J Neuroinflammation. 2014;11:95 pubmed 出版商
  346. Ying Y, Kim J, Westphal S, Long K, Padanilam B. Targeted deletion of p53 in the proximal tubule prevents ischemic renal injury. J Am Soc Nephrol. 2014;25:2707-16 pubmed 出版商
  347. Zhao X, Gao S, Ren H, Huang H, Ji W, Hao J. Inhibition of autophagy strengthens celastrol-induced apoptosis in human pancreatic cancer in vitro and in vivo models. Curr Mol Med. 2014;14:555-63 pubmed
  348. Havel J, Li Z, Cheng D, Peng J, Fu H. Nuclear PRAS40 couples the Akt/mTORC1 signaling axis to the RPL11-HDM2-p53 nucleolar stress response pathway. Oncogene. 2015;34:1487-98 pubmed 出版商
  349. Sun S, Han Y, Liu J, Fang Y, Tian Y, Zhou J, et al. Trichostatin A targets the mitochondrial respiratory chain, increasing mitochondrial reactive oxygen species production to trigger apoptosis in human breast cancer cells. PLoS ONE. 2014;9:e91610 pubmed 出版商
  350. Bhattacharyya S, Ghosh S, Sil P. Amelioration of aspirin induced oxidative impairment and apoptotic cell death by a novel antioxidant protein molecule isolated from the herb Phyllanthus niruri. PLoS ONE. 2014;9:e89026 pubmed 出版商
  351. Guerzoni C, Amatori S, Giorgi L, Manara M, Landuzzi L, Lollini P, et al. An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas. BMC Cancer. 2014;14:137 pubmed 出版商
  352. Pavet V, Shlyakhtina Y, He T, Ceschin D, Kohonen P, Perala M, et al. Plasminogen activator urokinase expression reveals TRAIL responsiveness and supports fractional survival of cancer cells. Cell Death Dis. 2014;5:e1043 pubmed 出版商
  353. Annibaldi A, Heulot M, Martinou J, Widmann C. TAT-RasGAP317-326-mediated tumor cell death sensitization can occur independently of Bax and Bak. Apoptosis. 2014;19:719-33 pubmed 出版商
  354. Tao L, Zhou X, Shen C, Liang C, Liu B, Tao Y, et al. Tetrandrine induces apoptosis and triggers a caspase cascade in U2-OS and MG-63 cells through the intrinsic and extrinsic pathways. Mol Med Rep. 2014;9:345-9 pubmed 出版商
  355. Sanders Y, Liu H, Zhang X, Hecker L, Bernard K, Desai L, et al. Histone modifications in senescence-associated resistance to apoptosis by oxidative stress. Redox Biol. 2013;1:8-16 pubmed 出版商
  356. Zhang Y, Lu Q, Cai X. MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3. FEBS Lett. 2013;587:3069-75 pubmed 出版商
  357. Song J, Peng X, Ji M, Ai M, Zhang J, Dong W. Hugl-1 induces apoptosis in esophageal carcinoma cells both in vitro and in vivo. World J Gastroenterol. 2013;19:4127-36 pubmed 出版商
  358. Brinkmann K, Hombach A, Seeger J, Wagner Stippich D, Klubertz D, Kronke M, et al. Second mitochondria-derived activator of caspase (SMAC) mimetic potentiates tumor susceptibility toward natural killer cell-mediated killing. Leuk Lymphoma. 2014;55:645-51 pubmed 出版商
  359. Piedfer M, Bouchet S, Tang R, Billard C, Dauzonne D, Bauvois B. p70S6 kinase is a target of the novel proteasome inhibitor 3,3'-diamino-4'-methoxyflavone during apoptosis in human myeloid tumor cells. Biochim Biophys Acta. 2013;1833:1316-28 pubmed 出版商
  360. Mo Q, Chen P, Jin X, Chen Q, Tang L, Wang B, et al. Inhibition of Hec1 expression enhances the sensitivity of human ovarian cancer cells to paclitaxel. Acta Pharmacol Sin. 2013;34:541-8 pubmed 出版商
  361. Faccenda D, Tan C, Seraphim A, Duchen M, Campanella M. IF1 limits the apoptotic-signalling cascade by preventing mitochondrial remodelling. Cell Death Differ. 2013;20:686-97 pubmed 出版商
  362. Li L, Yang G, Ren C, Tanimoto R, Hirayama T, Wang J, et al. Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2. Mol Oncol. 2013;7:484-96 pubmed 出版商
  363. Nakamura K, Aizawa K, Nakabayashi K, Kato N, Yamauchi J, Hata K, et al. DNA methyltransferase inhibitor zebularine inhibits human hepatic carcinoma cells proliferation and induces apoptosis. PLoS ONE. 2013;8:e54036 pubmed 出版商
  364. Jung Y, Joo K, Seong D, Choi Y, Kong D, Kim Y, et al. Identification of prognostic biomarkers for glioblastomas using protein expression profiling. Int J Oncol. 2012;40:1122-32 pubmed 出版商
  365. Cazanave S, Mott J, Bronk S, Werneburg N, Fingas C, Meng X, et al. Death receptor 5 signaling promotes hepatocyte lipoapoptosis. J Biol Chem. 2011;286:39336-48 pubmed 出版商
  366. Xargay Torrent S, Lopez Guerra M, Saborit Villarroya I, Rosich L, Campo E, Roué G, et al. Vorinostat-induced apoptosis in mantle cell lymphoma is mediated by acetylation of proapoptotic BH3-only gene promoters. Clin Cancer Res. 2011;17:3956-68 pubmed 出版商
  367. Piedfer M, Dauzonne D, Tang R, N Guyen J, Billard C, Bauvois B. Aminopeptidase-N/CD13 is a potential proapoptotic target in human myeloid tumor cells. FASEB J. 2011;25:2831-42 pubmed 出版商
  368. Takei H, Buckleair L, Powell S. Immunohistochemical expression of apoptosis regulating proteins and sex hormone receptors in meningiomas. Neuropathology. 2008;28:62-8 pubmed
  369. Kim B, Chung H. Hypoxia/reoxygenation induces apoptosis through a ROS-mediated caspase-8/Bid/Bax pathway in human lymphocytes. Biochem Biophys Res Commun. 2007;363:745-50 pubmed
  370. Malhi H, Barreyro F, Isomoto H, Bronk S, Gores G. Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity. Gut. 2007;56:1124-31 pubmed
  371. Martin Latil S, Mousson L, Autret A, Colbere Garapin F, Blondel B. Bax is activated during rotavirus-induced apoptosis through the mitochondrial pathway. J Virol. 2007;81:4457-64 pubmed
  372. Sun B, Sun Y, Wang J, Zhao X, Wang X, Hao X. Extent, relationship and prognostic significance of apoptosis and cell proliferation in synovial sarcoma. Eur J Cancer Prev. 2006;15:258-65 pubmed
  373. Cherian S, Bobryshev Y, Tran D, Sivaraman A, Lord R, Cherian K. Cellular destruction following transmyocardial laser revascularization (TMR). J Mol Histol. 2005;36:275-80 pubmed
  374. Bassarova A, Nesland J, Sedloev T, Danielsen H, Christova S. Pilomatrix carcinoma with lymph node metastases. J Cutan Pathol. 2004;31:330-5 pubmed
  375. Kim L, Nadarajah V, Peh S, Poppema S. Expression of Bcl-2 family members and presence of Epstein-Barr virus in the regulation of cell growth and death in classical Hodgkin's lymphoma. Histopathology. 2004;44:257-67 pubmed
  376. Rassidakis G, Jones D, Lai R, Ramalingam P, Sarris A, McDonnell T, et al. BCL-2 family proteins in peripheral T-cell lymphomas: correlation with tumour apoptosis and proliferation. J Pathol. 2003;200:240-8 pubmed
  377. Korkolopoulou P, Lazaris A, Konstantinidou A, Kavantzas N, Patsouris E, Christodoulou P, et al. Differential expression of bcl-2 family proteins in bladder carcinomas. Relationship with apoptotic rate and survival. Eur Urol. 2002;41:274-83 pubmed
  378. Sjöström J, Blomqvist C, von Boguslawski K, Bengtsson N, Mjaaland I, Malmström P, et al. The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer. Clin Cancer Res. 2002;8:811-6 pubmed
  379. Goetzl E, Kong Y, Mei B. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax. J Immunol. 1999;162:2049-56 pubmed